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A B S T R A C T
Background
Contracts are a verbal or written agreement that a patient makes with themselves, with healthcare practitioners, or with carers, where
participants commit to a set of behaviours related to the care of a patient. Contracts aim to improve the patients’ adherence to treatment
or health promotion programmes.
Objectives
To assess the effects of contracts between patients and healthcare practitioners on patients’ adherence to treatment, prevention and health
promotion activities, the stated health or behaviour aims in the contract, patient satisfaction or other relevant outcomes, including
health practitioner behaviour and views, health status, reported harms, costs, or denial of treatment as a result of the contract.
Search methods
We searched: the Cochrane Consumers and Communication Review Group’s Specialised Register (inMay 2004); the Cochrane Central
Register of Controlled Trials (CENTRAL), (The Cochrane Library 2004, issue 1); MEDLINE 1966 to May 2004); EMBASE (1980
to May 2004); PsycINFO (1966 to May 2004); CINAHL (1982 to May 2004); Dissertation Abstracts. A: Humanities and Social
Sciences (1966 to May 2004); Sociological Abstracts (1963 to May 2004); UK National Research Register (2000 to May 2004); and
C2-SPECTR, Campbell Collaboration (1950 to May 2004).
Selection criteria
We included randomised controlled trials comparing the effects of contracts between healthcare practitioners and patients or their carers
on patient adherence, applied to diagnostic procedures, therapeutic regimens or any health promotion or illness prevention initiative
for patients. Contracts had to specify at least one activity to be observed and a commitment of adherence to it. We included trials
comparing contracts with routine care or any other intervention.
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Data collection and analysis
Selection and quality assessment of trials were conducted independently by two review authors; single data extraction was checked by
a statistician. We present the data as a narrative summary, given the wide range of interventions, participants, settings and outcomes,
grouped by the health problem being addressed.
Main results
We included thirty trials, all conducted in high income countries, involving 4691 participants. Median sample size per group was 21.
We examined the quality of each trial against eight standard criteria, and all trials were inadequate in relation to three or more of these
standards. Trials evaluated contracts in addiction (10 trials), hypertension (4 trials), weight control (3 trials) and a variety of other areas
(13 trials). Fifteen trials reported at least one outcome that showed statistically significant differences favouring the contracts group,
six trials reported at least one outcome that showed differences favouring the control group and 26 trials reported at least one outcome
without differences between groups. Effects on adherence were not detected when measured over longer periods.
Authors’ conclusions
There is limited evidence that contracts can potentially contribute to improving adherence, but there is insufficient evidence from large,
good quality studies to routinely recommend contracts for improving adherence to treatment or preventive health regimens.
P L A I N L A N G U A G E S U M M A R Y
Contracts between patients and healthcare practitioners for improving patients’ adherence to recommended healthcare activities
Sometimes patients do not complete a course of treatment or they do not follow recommended changes in diet or personal habits.
This poor adherence may be because treatments take a long time, have side effects or involve changing patients’ habits, which is often
difficult. Several interventions aim to change the relationship between patients and healthcare practitioners in order to improve the
patients’ adherence to treatments. One of these interventions is in the form of contracts between healthcare practitioners and patients,
by which one or both parties commit to a set of behaviours related to the care of the patient. Contracts may be written or verbal.
Most contracts are between healthcare practitioners and patients, but they may also occur between practitioners and carers, carers and
patients or by a patient with him/herself. In this review we assessed whether contracts between practitioners and patients really improve
the patients’ adherence to treatment or their health status. We also assessed the effects of contracts on other outcomes, including patient
participation and satisfaction, health practitioner behaviour and views, health status, harms, costs, and ethical issues.
We found 30 trials involving 4691 participants, examining several types of contracts. The main health problems targeted were substance
addictions, hypertension and overweight. Many of the trials were of poor quality and involved small numbers of people. Most were
conducted in the USA. In 15 of the trials there was at least one outcome showing statistically significant differences in favour of the
contracts group (although some of the improvements in adherence did not remain when measured after a longer period). In six trials at
least one outcome showed such differences in favour of the control group. In 26 trials there was at least one outcome for which there
was no difference between the contract and control groups.
There is not enough reliable evidence available to recommend the routine use of contracts in health services to improve patients’
adherence to healthcare activities or other outcomes.
B A C K G R O U N D
For many treatments and health promotion strategies, participants
need to take advantage of the advice, treatments and other ac-
tions offered by healthcare practitioners. A number of good stud-
ies and systematic reviews have evaluated interventions to improve
patients’ adherence to treatments (Haynes 2008; Rueda 2006).
Haynes, for example, reports that interventions to improve short-
term adherence to medications are relatively successful, but inter-
ventions for chronic conditions tend to be complex and not very
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effective. One widely-used approach is a contract between health-
care practitioners and participants. We examine here the use of
contracts to improve adherence looking at the specific features of
contracts.
Definition and characteristics
Contracts are defined as a mutual agreement between two or more
parties that something shall be done by one or both (OED 2003).
As a behavioural strategy aiming at improving patients’ adherence,
contracts refer “to a process of specifying a set of rules regarding
some behaviour of interest and formalising a commitment to ad-
here to them” (Dunbar 1979). They are referred to as contracts,
behavioural contracts or contingency contracts. Contracts have
been used in a wide range of circumstances such as smoking ces-
sation, breast self examination, hypertension, diabetes, rheumatic
diseases, tuberculosis, hepatitis, for renal patients, and for people
with psychiatric conditions.
In the social science literature, there is no consistent definition of
contracts. This section aims to scope the features and concepts
underpinning the use of contracts in health and draws from a wide
range of research.
The following summarises the features of contracts when used as
a strategy to increase adherence:
• Formalisation. Contracts formalise the agreement of
patients and/or healthcare practitioners to follow treatment,
prevention or health promotion activities. These usually involve
therapeutic activities (particularly adherence to prescribed drugs)
but they also include: observance of appointments (Hayes 2000);
lifestyle behaviours, such as smoking cessation (Resnikow 1997)
and nutrition habits (Boehm 1997); and diagnostic actions, like
breast self examination (Lierman 1994). Contracts are often
written, but some examples of verbal contracts exist (Anderson
1982; Arnet 2000).
• Parties to the contract. Contracts are most often established
between patients and their physicians. There are examples of
other parties being involved, such as nurses and patients (Boehm
1997), patients and selected partners from the household or the
community (Keane 1984; Lierman 1994; Morisky 2001;
Ossip-Klein 1984), and even contracts with the patients
themselves (a self-commitment made explicit) (Brus 1998). We
found one study of a tripartite contract: between the patient, the
healthcare practitioner of a pain clinic and the primary care
physician (Fishman 2002a).
• Usually adults. In the literature, contracts primarily involve
adult patients, although adolescents (Morisky 2001; Wysocki
1989) and children (Greenan-Fowler 1987; Sherman 1991) have
also been involved. The role of children is particularly delicate,
since their decision capacity is limited and sometimes delegated
to their carers, and their right to have access to information
entails specific requirements to ensure their comprehension
(Sanz 2003).
Contingency contracts
When contracts include a reward conditioned by the accom-
plishment of the contract clauses, they are referred to as contin-
gency contracts: “a specifically negotiated agreement that provides
for the delivery of positive consequences contingent on desirable
behaviour” (Janz 1984). There are two main types of rewards
(Christiensen-S. 1985). ’Token economies’, which were initially
used as a behavioural therapy, are rewards from the healthcare
practitioner in the form of tokens that can be exchanged for some-
thing of value (Hayes 2000; Wysocki 1989). Rewards may also
involve the refund of a deposit (’deposit contract’) (Chowdhury
1997; Molteni 1983; Paxton 1983). One study reported a self-
reward, where the patient states what s/he will do to reward him/
herself (Neale 1991). Another study involved insurance refund
policies based on measures of treatment success (Harzer 2000).
Neither contingencies nor penalties seem to take place, however, if
healthcare practitioners do not respect their terms in the contracts.
Ethical issues arise when access to treatment may be dependent
upon patients’ behaviour as specified in a contract (Biller 1999).
Contracts have been used not only as behavioural therapy, but
also to support decisions on the appropriateness of a given treat-
ment. For example, one study described how compliance with a
behavioural contract was used as a criterion to identify individ-
uals with the potential to maintain a transplanted organ capably
(Cupples 2001). The circumstances in which a patient can make
a rational and autonomous choice, in the context of contracting,
is also worthy of ethical consideration (Biller 1999).
For this review, contracts are defined as any type of agreement,
verbal or written, by which one or both parties agree to a set of
behaviours related to the care of a patient. Contracts may be es-
tablished between healthcare practitioners and patients, between
practitioners and carers, between carers and patients, or by a pa-
tient with him/herself. Contracts are intended to improve adher-
ence to treatment, prevention and health promotion activities.
Theoretical models
Concordance and the relationship model
Compliance or adherence has been defined as “the extent to which
a person’s behaviour (in terms of taking medications, following di-
ets or executing lifestyle changes) coincides with medical or health
advice” (Haynes 1979a). The increasing use of the term ’adher-
ence’ instead of ’compliance’ is due to the latter’s negative and
authoritarian connotations. Adherence implies the patient’s active
choice in following medical recommendations rather than passive
co-operation of obedience to them (Evangelista 2000). However,
adherence is still rooted in a medical model, in which patients
are expected to do what healthcare practitioners tell them. In this
review, we use the term adherence in its most restricted sense, to
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designate the extent to which something that has been implicitly
or explicitly agreed between healthcare practitioners and patients
(for example, a treatment), actually happens, regardless of the type
of relationship between patients and practitioners.
The term ’concordance’ aims to reflect that patients/persons have
self-determination and control over what happens to them. Con-
cordance means shared decision making and arriving at an agree-
ment that respects patients’ wishes and beliefs (Jones 2003). It has
been argued that healthcare practitioners may also find that pa-
tients’ difficulties in adhering to treatments - such as those expe-
rienced by chronically-ill patients with their treatments (for ex-
ample, taking treatments consistently whilst suffering side effects)
- may be minimised in the context of a concordant relationship
(Townsend 2003).
Some contracts depend on a relationship model. Contrary to the
assumptions in a concordant relationship, the healthcare practi-
tioner perspective predominates in the literature on behavioural
contracts scrutinised so far. References to healthcare practitioners’
obligations (like providing information or evidence-based treat-
ments) are generally missing. Contracts often appear not to be
based on a relationship marked by shared decision making, but
instead they place the responsibility of failing the terms of the
contract on the patients’ side. The literature around concordance
is particularly relevant since it provides a critical perspective to
understand the patient - provider relationship, whatever form it
takes (including contracts). With concordance, an essential com-
ponent in a shared decision-making model is that of mutual agree-
ment (implicit or explicit) with the treatment decision (Charles
1997). This kind of agreement may indeed reinforce the mutual
contribution of healthcare practitioners and patients to a success-
ful treatment (Maher 2003). Furthermore, it has been argued that
unless patients and doctors are collectively or jointly involved in
the decision-making process, sharing information and building up
consensus, there is no basis for reaching an agreement on which a
treatment can be implemented (Stevenson 2000). In a concordant
consultation the patient and the healthcare professional partici-
pate as partners to reach that agreement (Cox 2004).
Impact on health
Lowadherencemay seriously compromise the effectiveness of ther-
apeutic regimens. It has been reported that adherence may be as
low as 10% in keeping appointments (number of appointments
kept in relation to the total number of appointments scheduled),
or may be between 40% and 60% in the case of adherence to
long-term medications (percentage of patients with presence of
medications in body fluids or self-assessed reporting of drug in-
take) (Sackett 1979). Poor adherence to treatment regimens has
been associated with a reduction in treatment effectiveness, lead-
ing to worse health outcomes and even death (Cleemput 2002;
Gordis 1979; Simpson 2006). The World Health Organization
(WHO) report on adherence documents worse outcomes associ-
ated with poor adherence for conditions like hypertension, type-
2 diabetes and depression (WHO 2003). There is some evidence
that the costs involved in treating non-adherent patients are greater
than those involved in treating adherent ones (Cleemput 2002;
Heinssen 1995). In the United Kingdom (UK), it has been esti-
mated that missed appointments resulted in an economic loss of
250 million pounds sterling per year (DPP 2003). However, ad-
herence to potentially harmful treatments may also lead to adverse
outcomes (Simpson 2006).
Advantages of contracts
What are the potential advantages of contracts over other inter-
ventions that seek to improve adherence and concordance? First,
they could allow for better replication if they are standardised
and do not include extensive training or educational components.
Contracts may be cheaper to implement than other combined or
more complex interventions, or even than supervised self-admin-
istration of drugs (Keane 1984). Apart from that, in a case study,
contracts have shown cost savings related to an increase in adher-
ence and the rationalisation of the care provided (Heinssen 1995).
For patients/participants, provided that the interventions used are
effective, the benefits include health gains, psychological comfort
(Jones 2003) and a better understanding of what they are expected
to do and why.
Evidence base for improving adherence
Haynes reviewed the factors associated with the level of adher-
ence to therapeutic regimens (Haynes 1979b). The type of dis-
ease seems to play a secondary role, except in specific conditions:
adherence tends to be lower in some psychiatric disorders such as
depression, for example. System or organisational issues such as
referral delays, waiting times and appointment schedules have a
stronger influence than the type of disease on the level of patients’
adherence. In relation to the features of the therapeutic regimens,
low adherence has been found almost constantly in treatments of
longer duration and involving several drugs. Socio-economic bar-
riers, side effects of treatments and denial of the illness have also
been related to poor adherence (Mellins 1992). Finally, the inter-
action between patients and healthcare practitioners is decisively
important in ensuring that what has been explicitly or implicitly
agreed, actually takes place. Effective communication of usage in-
structions for drugs, and the clinician’s understanding of patients’
concerns about their problems or treatment preferences, have been
associated with an increase in patients’ adherence and willingness
to participate (Hulka 1979).
Interventions to increase adherence may address organisational is-
sues, the simplification of therapeutic regimens, the interface be-
tween the patient and the healthcare practitioner, and patients’
behaviour. Strategies to increase adherence to regimens have been
systematically reviewed in general (Haynes 2008), and in rela-
tion to specific diseases, like tuberculosis (Volmink 2000; Volmink
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2006), HIV/AIDS (Rueda 2006) or mental illness (Reda 2001),
reporting the effects of these interventions on patients’ adherence
and on other outcomes. These interventions tend to be complex.
Firstly, many different actors and activities may be involved. Edu-
cational interventions, for example, may involve physicians, other
therapists, facilitators, educational materials, and different sched-
ules and structures of the sessions. Secondly, some interventions
are a combination of different strategies, such as patient instruc-
tions combined with visits to a specialist, or patient brochures to-
gether with group sessions. This complexity makes it very difficult
to know which are the key elements that may have an impact on
patients’ adherence or on the improvement of health outcomes.
Results from these reviews indicate that some strategies or combi-
nation of strategies may improve adherence or health outcomes,
but their effects are not very remarkable overall when compared
with the effort they require (Haynes 2008).
While this review focuses on a single strategy in the context of any
health condition, several systematic reviews have assessed interven-
tions to improve adherence or compliance in relation to specific
conditions. Five included contracts. One was restricted to adher-
ence to appointment keeping, and considered only randomised
controlled trials written in English (Macharia 1992). Another as-
sessed controlled studies, published in English language journals,
of patients’ adherence to therapeutic regimes (Roter 1998). Three
other reviewswere published inTheCochrane Library.One of them
focused on tuberculosis (Volmink 2006), another on reminder
packaging (Heneghan 2006) and yet another considered adher-
ence to prescribed (self-administered) medications only (Haynes
2008). No systematic review has addressed contracts as a strategy
to improve patients’ adherence to any kind of treatment, preven-
tion or health promotion activity, regardless of the setting and the
condition or disease affecting the patients.
O B J E C T I V E S
To assess the effects of contracts between patients and healthcare
practitioners on patients’ adherence to treatment, prevention and
health promotion activities, the stated health or behaviour aims
in the contract, patient satisfaction or other relevant outcomes,
including health practitioner behaviour and views, health status,
reported harms, costs, or denial of treatment as a result of the
contract.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs).
After the initial publication of the protocol for this review, we
amended the selection criterion for studies (which formerly in-
cluded some study designs other than RCTs). Preliminary search-
ing indicated that the number of randomised controlled trials
potentially eligible for inclusion in this review was much larger
than previously anticipated, thereby removing the need to examine
studies providing less robust evidence. The ’Criteria for consider-
ing studies for this review / Types of studies’ section was amended
to include only RCTs (excluding quasi-randomised trials, con-
trolled before-and-after studies and interrupted time series analy-
ses).
Types of participants
Patients or their carers, of any gender and age, with any health con-
dition and in any health setting. The term ’patient’ is used broadly
to refer to any person undergoing diagnostic tests, or treatment,
or participating in any illness prevention or health promotion ini-
tiatives.
Practitioners, including clinicians, nurses and any worker or ser-
vice providing screening, diagnosis, therapeutics, rehabilitation,
prevention or health promotion activities.
Types of interventions
Contracts concerning treatment, prevention and health promo-
tion activities aimed at improving patients’ adherence. Contracts
included any verbal or written statement specifying at least one
treatment, prevention or health promotion activity to be observed,
and a commitment of adherence to it.
Contracts could take place between healthcare practitioners or ser-
vices and patients or their carers, between patients and their car-
ers, or between patients themselves (self-commitment). Contracts
could relate to any diagnostic procedure, therapeutic regimen, re-
habilitation measure, general health advice, referral instruction,
or any other activity or combination of activities involved in the
management of patients.
Explicit rewards (like tokens, cash or social benefits) may or may
not have been present. Self-management was included, providing
that self-management appears to be supported by any form of
contracting.
The control was any intervention (such as instructions, education,
incentives or reminders) or combination of interventions, aimed
at improving patients’ adherence; or no intervention. We excluded
studies comparing different modalities of contracts.
We included studies of multifaceted interventions provided that
a given modality of contract was present in the intervention but
not in the control group.
Types of outcome measures
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Primary outcomes
• Patients’ adherence or change in behaviour related to
adherence (e.g. patients’ adherence to treatment regime, to
undergo a diagnostic procedure, to participate in a health
promotion programme, consistency with agreed targets,
attendance, participation number and rates, length or duration
of participation, healthcare practitioners’ adherence to agreed
specifications).
Secondary outcomes
• Patients’ participation in the contractual process (such as
inclusion of patients’ values and preferences) and degree of
shared decision making where alternative treatment options are
present, assessed through qualitative statements or scales.
• Outcomes of agreed aims stated in the contracts, both for
patients and for healthcare practitioners.
• Patients’ satisfaction with the contracting process, assessed
either qualitatively or through scales. This includes satisfaction
with the level of knowledge about the healthcare process,
reduction in the level of distress and other psychological
outcomes reported.
• Healthcare practitioners’ observance of contract terms and
appraisal of the contracting process.
• Health status measures: all outcomes consistent with, or
relevant to, the aims/specifications of contracts (e.g. for
treatment, prevention or health promotion, including mortality
and morbidity outcomes, improvement in the control of chronic
conditions and relief of symptoms).
• Harms associated with adhering to proposed treatment or
health promotion activity, (e.g. reported side effects, defaulted
treatment, and difficulties associated with maintaining treatment
or health promotion activities).
• Costs or savings incurred by patients, healthcare
practitioners, services or other institutions (e.g. insurance
companies) derived from adherence or non-adherence to
healthcare activities.
• Denial or deferral of treatment.
• A post-hoc outcome related to the utilisation of health
services has been added, as it has been found in one of the trials
and we think it is relevant in this review.
Although an association between adherence to drug therapy and
positive health outcomes has been shown (Simpson 2006), this
does not necessarily mean that good adherence to medication will
always predictably lead to better health outcomes (Haynes 2008).
However, we still think that it is of value to include studies with
only adherence-related outcomes, because certainly good adher-
ence may be a pre-requisite, although not the only one, for achiev-
ing good health outcomes.
Search methods for identification of studies
We sought studies in any language regardless of their publication
status (published, unpublished, in press and in progress).
We searched the following electronic databases using specific
search terms in combination with the search strategy for identify-
ing trials, as detailed in Appendix 5b of the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2006):
• Cochrane Consumers and Communication Review Group’s
Specialised Register (in May 2004).
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2004, issue 1) .
• MEDLINE (1966 to May 2004).
• EMBASE (1980 to May 2004).
• PsycINFO (1966 to May 2004).
• CINAHL (1982 to May 2004).
• Dissertation Abstracts. A: Humanities and Social Sciences
(1966 to May 2004).
• Sociological Abstracts (1963 to May 2004).
• UK National Research Register (2000 to May 2004).
• C2-SPECTR, Campbell Collaboration (1950 to May
2004).
We present the full search strategy for MEDLINE (Ovid) at
Appendix 1. We searched the reference lists of relevant studies
identified by the search.
Data collection and analysis
Study selection
One author (XBC) assessed the titles and abstracts of potentially-
relevant studies against the review inclusion criteria. If a study
could not be excluded on the basis of the title or abstract alone,
we obtained full papers. Two authors (XBC and KA) assessed po-
tentially-relevant papers for inclusion independently against the
review inclusion criteria. We resolved disagreements through dis-
cussion and, if an agreement was not reached, referred to a third
author (PG). Reports were scrutinised for multiple publication.
We excluded potentially-relevant studies that did not meet the
inclusion criteria, giving the reasons for exclusion in the table
Characteristics of excluded studies. We attempted to contact some
study authors for clarification where information was missing, but
the age of some of the trials, together with authors’ resource con-
straints, meant that this was not always possible. We aim to in-
crease author contact for future updates of this review.
Assessment of methodological quality
Two authors (XBC and KA) assessed independently the quality of
studies (see criteria below). This process was not blind in relation
to the trial authors, their institutions and journals.
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We used a form to guide the assessment of methodological quality,
and classified each quality component as ’adequate’, ’inadequate’
or ’unclear’. Disagreement was resolved by discussion with the
third author (PG).
The criteria applied to assess the methodological quality were as
follows:
1. Method of randomisation: rated ’adequate’ if the method
used was described and the resulting sequences were
unpredictable (e.g. random numbers, drawing of lots or
envelopes, tossing a coin); rated ’inadequate’ if the sequences
could be related to non-random factors (e.g. record number, date
of birth); rated ’unclear’ if the description did not allow us to
judge the method of randomisation.
2. Concealment of allocation: rated ’adequate’ if participants
and investigators could not foresee the assignment (e.g. central
randomisation remote from trial location; sequentially
numbered, opaque, sealed envelopes); rated ’inadequate’ if
participants and investigators enrolling participants could foresee
the upcoming assignment (e.g. open allocation schedule;
unsealed or non-opaque envelopes); rated ’unclear’ if the
description did not allow us to judge allocation concealment. In
the table Characteristics of included studies allocation
concealment was reported as: adequate (A), unclear (B),
inadequate (C), or that allocation concealment was not used (D)
as a criterion to assess validity (Higgins 2006, chapter 6.3).
3. Blinding of practitioners: rated ’adequate’ if it was reported
that practitioners or researchers (those offering the intervention)
were blind to who was in each group; rated ’inadequate’ if
practitioners or researchers knew the participants’ group, and
this was stated or could be clearly inferred from the text; rated
’unclear’ if the description did not allow us to judge blinding of
practitioners.
4. Blinding of participants: rated ’adequate’ if participants did
not know to which group they belonged; rated ’inadequate’ if
participants knew to which group they belonged; rated ’unclear’
if the description did not allow us to judge blinding of
participants.
5. Blinding in the assessment of outcomes: rated ’adequate’ if
trial authors explicitly stated that the primary outcome variables
were assessed blindly; rated ’inadequate’ if outcome(s) were not
assessed blindly; rated ’unclear’ if the description did not allow
us to judge blinding of outcome assessment.
6. Baseline measurements: rated ’adequate’ if baseline
measurements were reported and there were no significant
differences between groups; rated ’inadequate’ if baseline
measurements were reported and there were significant
differences between groups; rated ’unclear’ if baseline
measurements were not reported.
7. Loss to follow up: rated ’adequate’ if outcome measures
were explicitly obtained for 80% or more of professionals,
subjects, patients or episodes entering the study; rated
’inadequate’ if outcome measures were obtained for less than
80% of professionals, subjects, patients or episodes entering the
study; rated ’unclear’ if it was not reported or it was impossible
to estimate.
8. Consumer participation: rated ’adequate’ if there was any
mention of the involvement of consumers in the design,
implementation or interpretation of the research; rated
’inadequate’ if it was explicitly stated that consumers did not
participate in any stage; rated ’unclear’ if nothing was reported.
The assessment of methodological quality for each included study
is reported in Table 1.
Data Extraction
Trials were distributed among two authors (XBC and KA) for
data extraction. The statistics editor and statistics assistant of the
Cochrane Consumers and Communication Group checked the
data extraction. Data extracted included the study design, meth-
ods, participants, interventions, co-interventions and outcomes.
Data extracted to describe the modality of contracts included: for-
malisation and duration of contracts, parties (categorised as prac-
titioner, participant/patient, carer (including peers and significant
others) and other), treatment, prevention and health promotion
activities involved, and contingencies. We also extracted data on
the profile of trial participants.
We extracted the following data on outcomes (for all parties, such
as for children and parents): measures of adherence to therapeutic
regimens and use of services; adherence of healthcare practitioners
to the terms of the contracts; penalties and rewards; quantitative
measures or qualitative data describing the level of shared decision
making; measures of satisfaction with the process; expectations
and psychological distress; healthcare practitioners’ understanding
and behaviour in relation to contracts; health status data, such as
improvement in clinical parameters or prognosis; cost informa-
tion, detailing (where possible) the way costs have been estimated;
and data on harms derived from the adherence or lack of adher-
ence to treatment/s.
Data Analysis
Where no intention-to-treat (ITT) analysis had been carried out,
we have tried to extract data to do it. Percentage loss to follow
up has been presented as reported, or calculated if the number
of selected individuals did not match the number of individuals
whose data has been analysed. For binary outcomes we recorded
the number of participants experiencing the event in each group
and calculated the odds ratios. For continuous outcomes we ex-
tracted the arithmetic means and standard deviations (SD).
The main features of included studies have been presented in the
table Characteristics of included studies, which also includes the
country, setting, health area or problem, recruitment mechanism,
sample size of participants randomised and main features of con-
tracts. Additional tables Table 2; Table 3; Table 4; Table 5 (one for
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each main group of health problems or areas) describe the number
of participants included in the analysis (which may differ to the
number of participants randomised), the interventions, controls
and outcomes. For each study, outcomes have been placed in three
columns depending on whether there were statistically significant
differences favouring the intervention group, the control group or
there were no differences, respectively.
Trials were all too diverse in terms of co-interventions, control
groups, features of contracts, outcomes and settings to try any
grouping by those criteria. Although the initial sub-group anal-
yses options included health status outcomes, presence and type
of contingencies, degree of shared decision making and type of
healthcare activity, we decided that the clearest way to group tri-
als was by health area, because slightly more than half of the in-
cluded trials could be grouped into three health areas (addictions,
hypertension, and weight control). The remaining trials exam-
ined a range of conditions and are listed as ’miscellaneous’ in our
grouping. Data were presented by means of graphics only where
data were complete (numbers in all groups available for categorical
variables, and numbers in groups, means and standard deviations
for continuous variables).
Consumer participation
Given that this review was not limited to any particular condi-
tion, we sought input from consumers or patients whose health
experiences were not restricted to a single disease group and with
experience or involvement in issues related to the relationship be-
tween patients and healthcare practitioners. Consumer participa-
tion was ensured in the protocol stage, and in the development of
the review, and will be taken into account in future updates.
The protocol for this review, together with a user-friendly ques-
tionnaire in electronic format to guide the process, was sent to a
number of consumers for comments. Feedback was received from
the following people and institutions: a social sciences and gender
specialist working as aCommunity Research andTrainingConsul-
tant, who is familiar with consumers’ points of view (the Gender
and Health Group, Liverpool School of Tropical Medicine, Liver-
pool, UK), and the Director of Developing Patient Partnerships
(London, UK). The Cochrane Consumers and Communication
Review Group involved two other consumers as external peer-re-
viewers of the protocol, and one consumer as an external peer-
reviewer of the review. Additionally, several consumers involved in
The Cochrane Collaboration provided feedback directly to the re-
view authors at both protocol and review stages. Suggestions from
consumers have been incorporated into the protocol and review
as much as possible.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
As a type of intervention designed to help shape the relationship
between patients, carers and practitioners, contracts are extremely
complex, poorly defined and described, and evaluated in many
different formats and ways. The lack of a consistent definition and
common features, and the variation in trials undertaken, meant
that we had to select one sensible way to present the results. The
table Characteristics of included studies offers a summary of the
following features of the included studies:
• study design;
• participants, including: country, setting, health problem or
area, method of recruitment, type of participants and number of
participants being randomised;
• Intervention, including characteristics of contract (form,
parties, type of incentives and existence of co-interventions) and
groups to which participants were allocated.
• outcomes.
We outline below themain elements of the studies included in this
review, in terms of the selection of studies; location and setting;
health problems addressed; participants; interventions and control
groups.
Results of the search
The search strategy retrieved a total of 4191 titles and abstracts.
Of those, 768 items were duplicates, 3348 were irrelevant, and 75
appeared to be relevant. Of those 75 that were potentially relevant,
we excluded 43 papers and included 32.
Included studies
Two pairs of trials referred to the same trials presenting data from
two different follow-up periods: Piotrowski 1999 and Hartz 1999
being one pair, and Calsyn 1994 and Saxon 1996 the other. The
results of these studies are reported under the study identifiers
Piotrowski 1999 and Calsyn 1994, respectively. Schulman 1980
seemed to be based in the same setting as Swain 1981, although
it was unclear whether the data analysed came from the same set
of patients. For the moment, we have reported the results as two
trials but aim to clarify this in the future. The final number of
included trials is 30. The dates of published trials ranged from
1973 to 2001.
All included studies were randomised controlled trials. Six of them
(20%) used modified randomisation techniques (stratified and
cluster randomisation).
Location (country and setting)
The studies were based in the USA (26), UK (2), Canada (1) and
Australia (1). The main settings of trials were:
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• Specialised services (7): clinics specialising in providing care
for addictions, a geriatric centre and an optical centre;
• Primary health care (5);
• Hospital (2);
• Other settings (9) including specially set up programmes
for substance abuse, a weight loss programme for young girls and
other community based trials.
In seven (7) trials the setting could not be identified.
Health problems or areas
The included trials covered a wide range of health problems or
areas, including;
1. Addictions (10): these included alcohol (5 trials), smoking
(3 trials) and opiates (2 trials);
2. Hypertension (4);
3. Weight control (3);
4. Miscellaneous (13) included: diabetes, tuberculosis, breast
self examination, healthy diet for the elderly, acne, depression,
fear desensitising, acute antibiotics treatment, eye care,
rheumatoid arthritis, and asthma.
Participants
Participants in all trials were people receiving care for a disease
or who were targets for preventive interventions. In 13 trials they
were recruited from the health system (patients receiving care, at-
tending ambulatory services or referred). Eleven trials recruited
participants using adverts, two trials used both methods, and an-
other trial recruited college students. The recruitmentmethodwas
not described in one trial.
The median number of participants per group was 21 (interquar-
tile range 24 subjects). All trial participants were adults except
in: Aragona 1975 (overweight children); Burkhart 2002 (children
with asthma);Wurtele 1980 (screening for tuberculosis) where the
age of participants ranged from 5 to 76 years; and Morisky 2001
(adolescents treated for latent tuberculosis, aged 11 to 19).
Fourteen trials (47%) compared two groups, eight trials (27%)
had three groups, five trials (17%) had four groups, one trial (3%)
had five groups and two (7%) trials had six groups.
Intervention: characteristics of contracts
Format
Contracts were written in 25 trials (83%), and in the other 5 trials
(17%) their format was not stated. Only four trial reports (13%)
included a sample of the contract form (Litzelman 1993; Morgan
1988; O’Farrell 1984; Ossip-Klein 1984).
Parties
Contracts were mainly established between two parties: between
participants or patients and healthcare practitioners in seven trials
(23%), between participants or patients and carers, peers or sig-
nificant others in nine trials (30%), and between healthcare prac-
titioners and carers in one trial (3%). In four trials (13%) con-
tracts were tripartite between patients, carers and healthcare prac-
titioners. Two trials (7%) examined a self-contract. In the other
seven trials (23%) the parties involved in the contracts were not
reported. See the ’Characteristics of included studies table for de-
tails on each particular trial.
Terms and incentives
Terms
The terms of the contracts included:
1. Stopping or reducing substance abuse (alcohol, opiates,
tobacco) (Calsyn 1994; Curry 1988; Piotrowski 1999; Poole
1981).
2. Posting a prompt calendar in a prominent location, plus
attending after care sessions and calling the alcohol programme
in advance if unable to attend (Ossip-Klein 1984).
3. Recording disulfiram (Antabuse) intake which was mailed
to the treatment programme monthly (Keane 1984).
4. Attending sessions (Brockway 1977; Lash 1998).
5. Keeping record of drinks and limiting alcohol intake
(Vinson 2000).
6. Wives of participants observing and recording whether
disulfiram (Antabuse) was taken by their husbands, and in return
they avoid mentioning any fears of their husband’s future
drinking, with instructions on when to search for medical care
(O’Farrell 1984).
7. Practicing muscular relaxation (Hoelscher 1986).
8. Exercising (Craighead 1989; Murphy 1982; Swain 1981).
9. Changing eating habits (Morgan 1988; Murphy 1982;
Swain 1981).
10. Setting goals for children’s weight loss (Aragona 1975).
11. Working on a manual for phobia desensitising (Barrera
1977).
12. Following written instructions for contact lens care, reasons
for care and goals for successful care (Claydon 1997).
13. Monitoring Peak Expiratory Flow Rate (PEFR) (Burkhart
2002).
14. Returning for tuberculosis skin-test reading (Wurtele 1980).
15. Reminding about breast self examination (BSE) (Mayer
1991).
16. Monitoring use of hands, and pain (Hammond 1999).
17. Taking medication (Flanders 1985, Morisky 2001, Putnam
1994).
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18. Foot care behaviours (Litzelman 1993).
19. Following specified behaviours towards partners (McLean
1973).
One trial (3%) did not explicitly report the terms of the contract
(Binstock 1988).
Some of the contract terms included adherence to treatment (e.g.
return for tuberculosis skin-test reading). These are considered as
outcomes if they are presented as such in the studies, regardless of
whether they are also part of the contract’s terms.
Incentives
In 21 trials contracts had incentives attached to them, contingent
to the fulfilment of the contract terms. Incentives were of several
types:
• Five trials (17%) featured deposits. Participants delivered a
given amount of money to the researchers or healthcare
practitioners, which was then totally or partially reimbursed
upon completion of the terms of the contract (Aragona 1975;
Brockway 1977; Craighead 1989; Mayer 1991; Poole 1981).
• Three trials (10%) incorporated tokens or goods, such as
cash credits to be exchanged for items that participants chose, or
selection of a gift (Flanders 1985; Murphy 1982; Piotrowski
1999).
• Other incentives were used in 13 trials (43%), as follows:
changes in methadone dosage (Calsyn 1994); special meals and
recreational activity (Ossip-Klein 1984); rewarding activities
(Barrera 1977; Hoelscher 1986); self-defined rewards (Binstock
1988; Burkhart 2002; Morgan 1988), change of partner
behaviour (McLean 1973), praising and stickers (Burkhart
2002), punishment of sending money to someone participants
disliked (Curry 1988), random reward (Flanders 1985) and
unspecified rewards (Hoelscher 1986; Putnam 1994; Swain
1981; Wurtele 1980).
Contracts in nine trials (30%) had no incentives attached to them.
Co-interventions
Twenty-five trials (83%) had co-interventions (some of them had
more than one). It was not always clear whether an intervention
was part of the contract arrangement, or was actually a co-inter-
vention. For example, the terms of the contract in Ossip-Klein
1984 included posting a prompt calendar to remember specific
tasks, but this reminder mechanism could also be seen as a co-
intervention. Co-interventions included:
• Counseling/education/instructions (18 trials): Aragona
1975; Barrera 1977; Binstock 1988; Calsyn 1994; Claydon
1997; Curry 1988; Craighead 1989; Haber 1993; Keane 1984;
Lash 1998; Litzelman 1993; McLean 1973; Morgan 1988;
Morisky 2001; Murphy 1982; Schulman 1980; Swain 1981;
Vinson 2000.
• Training (skills or behaviours) (11 trials): Aragona 1975;
Binstock 1988; Brockway 1977; Burkhart 2002; Calsyn 1994;
Curry 1988; Hammond 1999; Hoelscher 1986; Mayer 1991;
O’Farrell 1984; Poole 1981.
• Reminders (4 trials): Burkhart 2002; Haber 1993; Mayer
1991; Morgan 1988.
• Group support/treatment (2 trials): Calsyn 1994; Haber
1993.
• Monitoring or recording of medication taken, problems
related to taking medication (2 trials): Flanders 1985; Keane
1984.
• Goal setting (1 trial): Calsyn 1994.
Control groups
Control groups consisted of routine care in 14 trials (47%). Non-
routine control groups included the following interventions:
• Counseling/education/instructions (8 trials): Binstock
1988; Calsyn 1994; Craighead 1989; Haber 1993; Keane 1984;
Morgan 1988; Morisky 2001; Swain 1981.
• Group support / treatment (5 trials): Curry 1988;
Hoelscher 1986; Mayer 1991; Murphy 1982; O’Farrell 1984.
• Training (5 trials): Binstock 1988; Calsyn 1994; Curry
1988; Hoelscher 1986; Poole 1981.
• Reminders (1 trial): Mayer 1991.
• Others (2 trials): cognitive re-structuring, role playing
(Curry 1988); supervised exercise (Craighead 1989).
Risk of bias in included studies
Eightmethodological quality criteria were applied to each trial (see
’Methods of the review / Assessment of methodological quality’,
for details). None of the trials met 5 or more of the 8 methodolog-
ical quality criteria; 1 trial met 4 criteria, 3 trials met 3 criteria, 6
met 2 criteria, 11 trials met a single criterion and the remaining 9
trials met none of the criteria. The assessment of methodological
quality for each included study is reported in Table 1.
Method of randomisation and concealment of
allocation
The randomisationmechanism to allocate participants into groups
was appropriately reported in three trials (Burkhart 2002; Curry
1988; Vinson 2000). In the other 27 trials it was not possible
to determine the randomisation mechanism, although none gave
any evidence of utilising a quasi-experimental rather than truly
randomised study design.
Only two trials mentioned a method which allowed for conceal-
ment of allocation (Ossip-Klein 1984; Vinson 2000); in 28 trials
(94%) allocation concealment was unclear.
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Baseline measurements
Baseline measurements were reported in 24 trials. No differences
in baseline measurements were reported in 16 trials, although only
9 of them showed baseline data. The other eight trials reported
some differences (six of them showing data).
Blinding
This behavioural intervention is difficult to blind to practitioners
andparticipants.Only four trials reported blinding of practitioners
or researchers (Litzelman 1993; Ossip-Klein 1984; Putnam 1994;
Swain 1981). In 22 trials blinding was not reported and in the
other 4 trials it was clearly stated that practitioners were not blind
to group allocation.
In 3 trials participants were blind to the allocated intervention
(Claydon 1997; Haber 1993; Hammond 1999), and the other 27
trials did not mention blinding of participants. In Claydon 1997,
it should be noted, patients were unaware of being participants in
a trial.
Blinded assessment of outcomes was reported in 6 trials (Claydon
1997;Hammond 1999;Hoelscher 1986; Litzelman 1993; Vinson
2000;Wurtele1980). In 23 trials it was unclear, and1 trial reported
that outcome assessors were not blind to group allocation.
Follow up
Loss to follow up was less than 20% (rated as ’adequate’) in 19
trials, more than 20% (rated as ’inadequate’) in 4 trials, and could
not be determined in the other 7 trials.
Community or user involvement
None of the trials reported any participation of community mem-
bers or users in the design, implementation or interpretation of
the research, beyond the involvement expected from a behavioural
intervention.
Data on outcomes
Nine of the 30 trials provided enough data to estimate statis-
tical differences between groups (Craighead 1989, Lash 1998,
Litzelman 1993,McLean 1973,Morisky 2001,Ossip-Klein 1984,
Piotrowski 1999, Poole 1981, Putnam 1994). The presentation of
numerical data was of poor quality: some statistical significances
were just mentioned in the text without P values; others had P
values but not the statistical parameter used (for example, F, t) or
their values; some did not show the number of subjects included
in the analyses of each group; and sometimes comparisons of more
than one intervention group were pulled together against more
than one control group pulled together as well.
Sample size
Sample sizes were generally small. The median sample size per
groupwas 21 (interquartile range 24), and only two trials hadmore
than 100 subjects in each group. With this very limited sample
size it is difficult to have the power to estimate relatively small
differences between groups.
Effects of interventions
The numerous outcomes were difficult to group in terms of their
meaning, methods of assessment and times of the assessments.
Therefore, it seemed impractical to attempt any pooling of data
for meta-analysis. However, for those outcomes where data were
complete (for example, standard deviations included when esti-
mating means, or the number of subjects included in the analy-
ses of each group), and where appropriate, we entered data into
RevMan Analyses and produced forest plots, as noted below.
Overall, 15 trials reported at least 1 outcome that showed statisti-
cally significant differences favouring the contracts group; six trials
reported at least one outcome that showed statistically significant
differences favouring the control group; and 26 trials reported
at least 1 outcome without statistically significant differences be-
tween groups (see tables 2 to 5).
We present a narrative summary below for each of the health areas.
Table 2; Table 3; Table 4; and Table 5 present all outcomes for
each individual trial.
1. Addictions
Ten trials (in 12 reports) examined the effects of contracts in the
context of substance addictions (Brockway 1977; Calsyn 1994;
Curry 1988; Keane 1984; Lash 1998; O’Farrell 1984; Ossip-Klein
1984; Piotrowski 1999; Poole 1981; Vinson 2000). See also Anal-
yses 1.1 to 1.7, and Table 2.
Adherence
Adherence was measured in three different ways: (i) period of time
abstinent (substance-free samples); (ii) proportion of participants
abstinent (substance-free samples); and (iii) adherence to attending
sessions (sensitisation sessions).
Substance abuse
(i) Period of time abstinent
In one trial (Calsyn 1994), people in the contract group were
abstinent for a longer period (asmeasured by positive urine analysis
at 9 weeks post-treatment) than people in the control group (result
as reported by triallists; no extractable data).
In another trial (Piotrowski 1999), differences in abstinence du-
ration were assessed at different time periods post treatment. No
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significant differences were found after 30 or 60 days of treatment;
but significant differences favouring the intervention group were
found in longer post-treatment intervals, up to 180 days. For all
participants (regardless the period of time they were on treatment)
and individual substances, the only statistically significant differ-
ences reported were in the case of benzodiazepines and marijuana
(favouring the intervention group). No differences were found for
alcohol, amphetamines, barbiturates and cocaine .
(ii) Proportion of participants abstinent
Calsyn 1994 reported the proportion of participants abstinent at
9 weeks and at 18months, measured by urine analysis. At 9 weeks,
the proportion of participants abstinent from opiates was signifi-
cantly higher in the intervention group, but there were no differ-
ences between groups for cocaine. At 18 months, a significantly
greater proportion of participants in the intervention group was
abstinent compared with the control group: (a) regardless of the
type of substance; (b) for cocaine, and; (c) for opiates. Detailed
data was only reported for the 18-month measurement point (see
Analysis 1.1).
In Piotrowski 1999 the proportion of participants in the contracts
group that were abstinent after 120 days of treatment showed no
difference with control group (measured by substance-free sam-
ples). (See Analysis 1.2).
(iii) Adherence to attending sessions
The percentage of participants present at sessions one to eight
showed statistically significant differences favouring the contracts
group for sessions one, three, four and six; but these differences
vanished for sessions two, five, seven and eight (Ossip-Klein 1984).
In another trial, there were no statistically significant differences
between groups in the number of participantswho attended at least
one aftercare group session nor in the mean number of aftercare
sessions attended (Lash 1998). (See Analysis 1.5 and Analysis 1.6).
Smoking
Contracts appeared to have little effect on participants’ abstinence
from smoking, when assessed in the included studies.
(i) Period of time abstinent
In one study (Poole 1981) the time remaining abstinent (measured
by self-reported daily cigarette consumption) was similar between
groups (measured at any time period from 1 week to 12 months).
(ii) Proportion of participants abstinent
In Curry 1988 the proportion of participants abstaining from
smoking at any period (from treatment up to more than three
months, measured by weekly self-reported cigarette consumption)
was also similar in both groups. In Brockway 1977 the participants
in the contracts group smoked significantly fewer cigarettes (mea-
sured by individual self-report) than people in the control group
at 6 months follow up. However this difference vanished at 12
months follow up. In Poole 1981 there was no difference between
participants in the control and contracts groups when cigarette
consumption was compared with baseline smoking, from 1 week
to 12 months follow up. (See Analysis 1.7).
Secondary outcomes
There were no differences between groups in any of the trials in the
following outcomes: dispensation of medication (Keane 1984),
participants’ satisfaction (O’Farrell 1984), change in Alcohol Use
Disorder IdentificationTest (AUDIT, a score to screen for drinking
problems) (Vinson 2000) and costs of treatments. (See Analysis
1.3).
O’Farrell 1984 measured participants’ abilities to solve problems,
and their perceptions about the treatment programmes, but the
study did not report any statistical analysis nor enough data to be
analysed post hoc.
A new outcome, related to the use of services, which was not fore-
seen at the protocol stage, is reported here. Contracts significantly
increased the discharge rate of patients under methadone therapy
(Calsyn 1994), because contingency contracting in this study in-
cluded discharge for continuous positive urine analysis. In other
words, contracts were unable to keep patients under treatment,
however participants in the contracts group were statistically sig-
nificantly less months out of treatment before readmission (i.e.
they were readmitted more after a shorter period than participants
in the control group).
2. Hypertension
Four trials examined the effects of contracts on a variety of out-
comes, in the context of hypertension management (Binstock
1988; Hoelscher 1986; Schulman 1980; Swain 1981). (See also
Table 3).
Adherence
Two trials reported adherence outcomes. Hoelscher 1986 exam-
ined the effects of contracts on relaxation practices. The ’group
relaxation’ (without contracts) group showed significantly better
adherence to the relaxation practices than the control group, which
itself showed better adherence than the ’group relaxation plus con-
tract’ group; that is, the group with contracts performed worst
in terms of adherence. In another study (Swain 1981), however,
fewer participants in the contracts group discontinued treatment,
compared with the control group.
Secondary outcomes
Two of the four trials reported blood pressure changes. Binstock
1988 did not find any difference between groups at one year follow
up. In Swain 1981, contracts statistically significantly improved
the diastolic blood pressure measured over four visits (specific time
periods not reported).
In Swain 1981, contracts significantly improved patients’ knowl-
edge about hypertension care issues. Participants’ views on health
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care were examined in one trial (Schulman 1980) through the Ac-
tive Patient Orientation scores reported by patients (health profes-
sionals support patients’ motivations reinforcing their active par-
ticipation, illness-management is collaborative, clear instructions
and skills training). Patients under contracts rated their care signifi-
cantly higher in theActive PatientOrientation scores. InHoelscher
1986, the cost-effectiveness (improvement in blood pressure per
hour of therapist contact) in the ’contracts plus group relaxation’
group was significantly higher than in the ’individual relaxation’
group.
3. Overweight
Three trials addressed contract interventions for overweight peo-
ple (Aragona 1975; Craighead 1989; Murphy 1982). (See also
Analysis 2.1; Analysis 2.2; and Table 4).
Adherence
None of the three trials reported adherence outcomes.
Secondary outcomes
In Aragona 1975 participants in the contracts group lost more
weight than those in the control groups, both at the end of treat-
ment (-11.3 pounds in the intervention group compared with -
9.5 and +0.5 pounds in the control groups), and at 8 weeks follow
up (-7.9 pounds in the intervention group compared with -5.0
and +3.6 pounds in the control groups).
In Craighead 1989 there were three groups: contracts, supervised
exercise and minimal contact. Outcomes were measured at 12
weeks and 12 months. When data from the contracts and super-
vised exercise groups were pooled, people in these groups lost sig-
nificantly more weight than those in the minimal care group. For
those participants who completed the treatments, mean weight
losses were respectively 8.1 pounds (contracts), 11 pounds (su-
pervised exercise) and 4.6 pounds (minimal contact) (P < 0.05)
(see Analysis 2.1). For longer term follow-up (12 months), mean
weight losses were 4.3 pounds (contracts), 10.6 pounds (super-
vised exercise) and 4.2 pounds (minimal contact) (P < 0.05). (See
Analysis 2.2). Craighead 1989 also collected data on the self-re-
ported helpfulness of the treatment: for this outcome there were
no statistically significant differences between the contracts group
and the supervised exercise group.
In Murphy 1982 there were no statistically significant differences
in any of the outcomes: mean weight loss, percentage of excess
weight loss and weight reduction index.
4. Miscellaneous
Thirteen other studies covered a wide variety of health problems
or areas, and were included in the miscellaneous category: Barrera
1977; Burkhart 2002; Claydon 1997; Flanders 1985;Haber 1993;
Hammond 1999; Litzelman 1993; Mayer 1991; McLean 1973;
Morgan 1988; Morisky 2001; Putnam 1994; Wurtele 1980. (See
also Table 5).
Acne
Flanders 1985 looked at the effects of contingent and non-contin-
gent contracting on compliance with acne treatment and number
of acne lesions. There was no difference in either of these outcomes
between contract and control groups. (See also Table 5).
Acute bacterial infections
Putnam 1994 assessed the effects of ’self-commitment’ on the ad-
herence to antibiotic treatment (score based on pill count) in pa-
tients suffering from acute bacterial infections. Adherence was sig-
nificantly better in the ’self-commitment’ group than in the con-
trol group. There were no differences between groups, however,
in self-reported adherence, nor in the number of additional pre-
scriptions required to finalise the treatment. (See Analysis 6.1 and
Table 5).
Arthritis
Hammond 1999 examined the effects of a joint protection pro-
gramme together with a contract on adherence to joint protection
(Joint Protection Behaviour Assessment-score measuring whether
twenty routine daily life tasks are performed correctly in order not
to cause joint damage) and to goals set in the joint protection pro-
gramme (self-reported joint protection homework), both showing
statistically significant improvements in the intervention group.
This effect was not observed in the second phase of the cross-over
trial. There were no differences between groups in knowledge or
health-related outcomes. (See also Table 5).
Asthma
A trial assessing a tripartite contractual approach (patients, prac-
titioners and parents) for monitoring Peak Expiratory Flow rate
(PEFR) in asthmatic children (Burkhart 2002) did not show any
differences between groups in adherence to PEFRmonitoring, nor
in the number of asthma episodes. (See also Table 5).
Breast self examination
One trial (Mayer 1991) looked at the effects of contracts between
female volunteers and healthcare practitioners on adherence to
breast self examination.Nodifferences were found between groups
in relation to either the frequency of breast self examination, or
the frequency of prompts by women’s partners. (See also Table 5).
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Contact lens care
Claydon 1997 examined the effects of a combined intervention
consisting of contracts, teaching materials (posters, video) and
reminders, on behaviours to take care of contact lenses, against
routine care. There were no differences between groups in any of
the targeted behaviours. (See also Table 5).
Depression
McLean 1973 evaluated the effects of contracts and training in
social learning principles on changing patients and their partners’
behaviours. Participants in the contract group, compared with
those receiving routine care, showed significant improvement of
targeted behaviours until 3 months follow up, as well as a decrease
in negative reactions at the time the treatment ended. (SeeAnalysis
5.1, and Table 5).
Diabetes
Litzelman 1993 and Morgan 1988 examined the effects of con-
tracts on the prevention of lower extremities abnormalities (mus-
culoskeletal and dermatological) associated with diabetes, and
on the treatment of type-II diabetes, respectively. Outcomes in
Litzelman 1993 included adherence outcomes (for example, wash-
ing the feet), health outcomes (for example, presence of foot le-
sions), and physician practice outcomes (for example, documen-
tation of clinical observations). Some items in all three cate-
gories showed statistically significant improvements in the con-
tracts groups (for example, reduction of serious foot lesions, of dry
or cracked skin, washing the feet, inspecting the shoes), and in
some other outcomes there were no differences between groups.
(See Analysis 3.1). Knowledge of diabetes and its care statistically
significantly improved in the control group (Morgan 1988), while
in the same trial weight loss, reduction of fasting blood glucose and
glycosylated haemoglobin were not statistically different between
groups (the sample size, both groups combined, was 60. Knowl-
edge was measured with the Diabetic Knowledge Scale (DIAKS),
a 60-item scale developed and tested for this study. (See also Table
5).
Phobia
The contracts intervention in Barrera 1977 aimed at reducing
participants’ phobia about snakes. The control group completed
significantly more desensitisation sessions, and took more time to
study the programme materials. At post-test and follow-up there
was no benefit in any outcome compared with self-administered
systematic desensitisation. (See also Table 5).
Promotion of healthy diet and exercise
Another trial (Haber 1993) examined the effects of a combined
intervention, including contracts, to reduce the amount of specific
dietary components (and to improve other health behaviours such
as exercise and stress management). The contracts group showed a
statistically significant increase in fibre and decrease in salt intake,
but showed no differences compared with the control group in
intake of fats and sweets, and on the use of stress management
techniques or practice of flexibility exercises. (See also Table 5).
Tuberculosis
Two trials related to tuberculosis adherence. One of them reported
adherence to returning for the skin test reading (Wurtele 1980),
which improved significantly in the intervention group. The other
examined adherence to medication regimen (Morisky 2001) be-
tween four groups: contingency contracts, peer counseling, a com-
bination of contracts and counseling, and usual care. Looking at
differences between the contracts group and the other three, only
a small difference significantly favouring the combination of con-
tracts plus counseling group was found. (See also Analysis 4.1, and
Table 5).
None of the included studies reported any of the following out-
comes: outcomes related to the contracts’ contingencies, harms,
or ethical issues.
D I S C U S S I O N
In this review we included 30 trials presented in 32 reports, the
majority set in the USA and all of them in high income countries.
The trials were undertaken in a range of settings (including some
projects and services that were established especially for research
purposes), and covered a wide range of health problems or areas,
contract forms, participants, and outcomes.
Most of the trials were of poor design, or were poorly reported,
or both. For example, only three trials reported their method of
randomisation and only two mentioned a method of randomisa-
tion which allowed for the concealment of group allocation. Poor
quality trials are more likely to be subject to bias and therefore the
results are less reliable than those from better quality trials (Schulz
1995). In addition, the sample size of many trials was small. Over
half the trials had more than two comparison groups, making
group sample sizes even smaller. Small trials are more likely than
larger trials to be insufficiently powered to detect statistically sig-
nificant differences between groups.
In 25 of the included trials, the intervention groups involved in the
contracting process also received other interventions intended to
improve the measured outcomes. In addition, in 16 of the trials, 1
or more control groups received interventions other than routine
care. It is therefore impossible, in most of the trials, to assess the
effects of contracts per se compared to routine care; an assessment
which would be very relevant for policy makers and consumers.
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Contracts were described in varying degrees of detail, but they
hardly met all assumptions as described by Quill (Quill 1983):
terms and conditions explicitly stated; parties have unique re-
sponsibilities; the relationship between practitioners and patients
is consensual, not obligatory; and all parties are able to negoti-
ate. Furthermore, in the concordance paradigm (Jones 2003) con-
tracts should not be simply understood as a way to engage patients
to comply with a predefined set of instructions, but rather as a
strategy to involve patients into a shared decision-making process
(Charles 1997). The requirements for shared decision making -
such as mechanisms for patients’ preferences to be taken into ac-
count, information sharing and commondecision on the regimens
to follow - were even more difficult to find in the included trials.
The great variety of health problems or areas, participants, inter-
ventions, control groups and outcomes precluded any attempt to
pool data for meta-analysis. The areas with the largest number of
trials were those of substance addictions and hypertension. The
data presented in the graphs has to be interpreted with caution,
because we only included trials and outcomes with complete sets
of data. Apart from one trial on adherence to antibiotic regimens
for acute bacterial infections (Putnam 1994), all trials were related
to chronic conditions.
Four of the seven trials dealing with alcohol or opiate addictions
reported statistically significant differences in several outcomes
favouring the contracts group. The findings in the review byMiller
(Miller 2002) placed behavioural contracts as one of the top 10
(out of 46) treatment modalities for alcohol abuse (although im-
portant publication bias could not be ruled out in that review).
However, some of those positive effects seen in our review were
not consistent in all repeated measures over time. We could not
identify any trial addressing the effects of opioid contracts in the
management of opioids for the relief of chronic pain; contracts
which are widely used but of doubtful efficacy (Fishman 1999).
In the area of smoking cessation (evaluated in three trials), our
findings seem to agree with those in a review examining another
behavioural intervention, namely competitions and incentives (
Hey 2005): studies were underpowered and of variable quality.
Furthermore, neither incentives, nor competitions, nor contracts,
seemed to enhance long-term cessation rates. In this review, the
only positive effect reported (mean number of cigarettes smoked at
several periods in time; Brockway 1977) vanished when measured
at 12 months follow up.
All three trials about hypertension that reported blood pressure
outcomes showednodifferences between groups onbloodpressure
measurements (except for better diastolic blood pressure in the
contracts group in Swain 1981). Adherence outcomes were both
better (Swain 1981) and worse (Hoelscher 1986) in the contracts
groups compared with the controls. Contracts in the context of
hypertension seem relatively unexplored, despite the fact that in
many countries blood pressure control falls far short of treatment
goals and the recognised relevance of behavioural interventions
to achieve those goals (Reunion 2006). The evidence from the
included trials supporting the use of contracts for hypertension
was very weak.
The external validity of the findings in the included trials is very
limited, due to several factors: their narrow geographical scope; the
settings which were specially established for research purposes in
most cases; the ways that participants were recruited (for example,
by advertisements); and the complexity and variety of contracts,
co-interventions and control group conditions, together with the
inconsistent descriptions of those interventions. All these features
discouraged any attempt to conduct a sub-group analysis, since
it would not be possible to control for each one of those factors.
In many cases it is difficult, if not impossible, therefore, to at-
tribute the effects seen to the impact of contracts alone. Further-
more, in many trials the selection criteria for participants were
very stringent. It seems unlikely that the findings of these trials can
be extrapolated to complex real situations as seen, for example, in
young black men of deprived communities in whom depression,
substance use (alcohol, tobacco and others), poor adherence and
poor blood pressure outcomes have all been identified as related
(Kim 2003).
There are some other critical factors to consider when deciding
whether to introduce contracting within a healthcare delivery sys-
tem. The included trials have addressed these factors little, if at all,
namely: acceptability of contracts to healthcare practitioners; par-
ticipants’, patients’ and carers’ satisfaction; costs; clinicians’ liabil-
ity, perpetuation of stigma in patients (Fishman 2002b); and eth-
ical considerations, especially where receiving treatment depends
on patients adhering to the terms of the contract, or where finan-
cial rewards are used. Some of the outcomes listed in the protocol
for this review addressed issues such as patients’ participation in
the contractual process, degree of shared decision making, harms
or ethical issues; but none of the trials reported data on them.
The lack of reporting on consumer participation highlights the
provider-centred approach, by which adherence is mainly seen as
a patient’s duty and practitioners remain in a patronising role; far
from the concordance model. This may be partially due to the
fact that most of the trials were conducted more than one decade
ago. Future studies should also address the issue of harms. We saw
in Hoelscher 1986 that the contracts group performed worse in
adhering to relaxation practices. But contracts might also reduce
the retention rate of patients, or affect the sincerity with which
patients report events that may breach the terms of the contract.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Contracts have been used as one among many other interventions
for improving adherence.
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• Trials testing this intervention are generally small, and for
many the quality is uncertain.
• Some trials have demonstrated a positive effect of forming a
contract in certain situations (for example, substance addiction),
particularly when combined with other interventions, although
it may be ineffective or harmful in other situations.
• There is not enough evidence to recommend the
widespread introduction of patient contracts into health services.
Implications for research
Existing small trials suggest that contracts may have a positive ef-
fect. This needs further evaluation with large, good quality ran-
domised controlled trials to assess the effectiveness of patient con-
tracts within established health systems. These should be:
• designed to allow the effects of contracts and any co-
interventions to be assessed separately, as well as in combination
where appropriate, taking into account the different features of
contracts.
• undertaken in health fields where adherence is particularly
important or problematic, and where patients and/or carers
think they may be valuable.
• undertaken in a range of settings where they might be
implemented if proven effective.
• designed to assess potential harms.
Reports of these trials should use a standard definition of contract
and describe the contract and contracting process in detail, includ-
ing the practitioner-patient relationship model and the extent of
consumers’ participation in the whole process.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Aragona 1975
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: other.
Health problem: overweight.
Recruitment: health system and adverts.
Participants: girls aged 5 to 11 who were overweight (n=15).
Interventions Contract features
• Form: written;
• Parties: practitioners-carers;
• Incentives: deposit;
• Co-interventions: yes.
Group1:Contracts betweenparents and the providers of a weight loss programme. Parents gave amonetary
deposit to the programme and received money back when their children achieved an agreed weight loss.
Group 2: As per group 1, but parents also contracted to facilitate their child’s weight loss by carrying out
reinforcement techniques.
Group 3: No contracts.
Outcomes Mean weight change (pounds) from start of treatment to end of treatment, and to 8 week follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Barrera 1977
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: NA.
Health problem: snake phobia.
Recruitment: adverts.
Participants: adults (n=24).
Interventions Contract features:
• Form: written;
• Parties: NA;
• Incentives: other;
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Barrera 1977 (Continued)
• Co-interventions: yes.
Group 1: Self administered desensitisation workbook.
Group 2: Self administered desensitisation workbook with contract to reward self for completion of
workbook.
Group 3: Placebo.
Outcomes Number of desensitisation sessions attended; time spent studying materials
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Binstock 1988
Methods Randomised controlled trial with five different groups; two with contracts and three without
Participants Country: USA.
Setting: PHC.
Health problem: hypertension.
Recruitment: health system.
Participants: adults (n=112).
Interventions Contract features:
• Form: written;
• Parties: NA;
• Incentives: other;
• Co-interventions: yes.
Group 1: Self-reward compliance contracts + educational program.
Group 2: Self-reward compliance contracts + educational programme + BP measurement at home +
calendar pills.
Group 3: Bi-monthly educational program.
Group 4: Educational + BP measurement at home.
Group 5: Calendar pills.
Outcomes Change of blood pressure from baseline to 1 year follow up.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Brockway 1977
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: speciality.
Health problem: addictions (smoking).
Recruitment: adverts.
Participants: adults (n=27).
Interventions Contract features:
• Form: NA;
• Parties: patients-practitioners;
• Incentives: deposit;
• Co-interventions: yes.
Experimental group: smoking cessation programme including contingency contracting (return of deposit
based on attendance at meetings and completion of assignments).
Control group: waiting list.
Outcomes Mean number of cigarettes smoked.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Burkhart 2002
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: NA.
Health problem: asthma.
Recruitment: health system.
Participants: children (n=42).
Interventions Contract features:
• Form: written;
• Parties: tripartite;
• Incentives: other;
• Co-interventions: yes.
Group 1: Contingency management (child contracted with parents and investigator to record daily peak
expiratory flow rate (PEFR)).
Group 2: Usual care.
Outcomes Adherence to PEFR monitoring over a 5 week period.
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Burkhart 2002 (Continued)
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Calsyn 1994
Methods Randomised controlled trial with six groups.
Participants Country: USA.
Setting: NA.
Health problem: addictions (opiate).
Recruitment: health system.
Participants: adult patients (n=353).
Interventions Contract features:
• Form: written;
• Parties: patients-practitioners;
• Incentives: other;
• Co-interventions: yes.
Three of the groups (Groups 1 to 3) included contingency contracting - treatment depending on reaching
goals for abstinence from illicit drugs.
Group 1: Medication only: saw counsellor to complete standard treatment.
Group 2: Standard: counselling sessions and optional drug education classes.
Group 3: Enhanced: as per Group 2 plus relapse prevention skill training group and weekly group
treatment
Groups 4, 5 and 6 mirrored the above groups but without the use of contingency contracts
Outcomes Rates of illicit drug and alcohol use, discharge rates and length of time to readmission for those discharged
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Claydon 1997
Methods Randomised controlled trial with two groups.
Participants Country: UK
Setting: speciality.
Health problem: contact lenses.
Recruitment: NA.
Participants: contact lens wearers (n=80).
Interventions Contract features:
• Form: written;
• Parties: patients-practitioners;
• Incentives: none;
• Co-interventions: yes.
Group 1: Teaching programme on contact lens care, including contract to sign.
Group 2: Usual care.
All participants received a free supply of contact lenses for a year
Outcomes Self reported contact lens care behaviours.
Notes Participants were unaware of being in a trial.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Craighead 1989
Methods Randomised controlled trial with three groups.
Participants Country: USA
Setting: other.
Health problem: overweight.
Recruitment: adverts.
Participants: women aged 18 to 30 and 15 to 45 pounds overweight (n=62)
Interventions Contract features:
• Form: written;
• Parties: NA;
• Incentives: deposit;
• Co-interventions: yes.
Group 1: Contracted exercise and written lessons.
Group 2: Instructions and supervised exercise.
Group 3: Instructions and minimal contact.
Outcomes Weight loss and Harvard Step Test fitness score at follow-up
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Craighead 1989 (Continued)
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Curry 1988
Methods Randomised controlled trial with four groups.
Participants Country: USA.
Setting: other.
Health problem: addictions (smoking).
Recruitment: adverts.
Participants: adult smokers (n=139).
Interventions Contract features:
• Form: written;
• Parties: NA;
• Incentives: other;
• Co-interventions: yes.
Two different smoking cessation programmes, one of which included contingency contracting. Both pro-
grammes were subdivided into self-help and group support groups. Participants with contracts contracted
to send $15 to a person or organisation they disliked if they smoked after their quit date
Outcomes Abstinence rates at 3, 6 and 9 months after treatment.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Flanders 1985
Methods Randomised controlled trial with four groups.
Participants Country: USA.
Setting: NA.
Health problem: acne.
Recruitment: other (screened as part of a larger study).
Participants: college students (n=42).
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Flanders 1985 (Continued)
Interventions Contract features:
• Form: written;
• Parties: NA;
• Incentives: tokens;
• Co-interventions: yes.
Group 1: Non-contingent contract (agreement to return self-monitoring cards) with education and self
monitoring medication card.
Group 2: Contingent contract (agreement to return self-monitoring cards with chance to win prizes for
each returned) with education and self monitoring medication card.
Group 3: Education and self-monitoring card.
Group 4: Waiting list.
Outcomes Acne cream compliance rate and number of acne lesions.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Haber 1993
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: speciality.
Health problem: healthy diet.
Recruitment: adverts.
Participants: adults over the age of 55 (n=64).
Interventions Contract features:
• Form: NA;
• Parties: NA;
• Incentives: none;
• Co-interventions: yes.
Experimental group: health education sessions plus peer group support sessions where behaviour changes
were agreed through group discussion and participants signed a contract to undertake these changes.
Control group: received health education classes only.
Outcomes Change in consumption of salt, sweets, fat and fibre. Practising of relaxation techniques and body move-
ments
Notes
Risk of bias
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Haber 1993 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Hammond 1999
Methods Randomised controlled cross-over trial.
Participants Country: USA.
Setting: NA.
Health problem: arthritis.
Recruitment: health system.
Participants: adults (n=35).
Interventions Contract features:
• Form: NA;
• Parties: NA;
• Incentives: none;
• Co-interventions: yes.
Experimental group: teaching joint protection techniques, including contracting as part of a goal-setting
and self-monitoring process, compared with no intervention.
Control group: later received the same intervention.
Outcomes Use of joint protection techniques at 12 and 24weeks.Measures of pain, functional disability, grip strength,
self-efficacy and helplessness
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Hoelscher 1986
Methods Randomised controlled trial with four groups, one of the groups using contracts
Participants Country: USA.
Setting: NA.
Health problem: hypertension.
Recruitment: adverts.
Participants: adults (n=50).
Interventions Contract features:
• Form: written;
• Parties: patients-carers;
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Hoelscher 1986 (Continued)
• Incentives: other;
• Co-interventions: yes.
Group 1: Group relaxation training plus contingency contracting. The contract specified daily or weekly
consequences to be given by the participant’s spouse for practicing relaxation exercises.
Group 2: Individual relaxation training.
Group 3: Group relaxation training.
Group 4: Waiting list.
Outcomes Compliance with relaxation exercises and changes in blood pressure at week 5 to 6 and week 9 to 10
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Keane 1984
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: Hospital (Veterans Administration Medical Center - Alcohol Dependence Treatment Program).
Health problem: addictions (alcohol).
Recruitment: health system.
Participants: men (n=25).
Interventions Contract features:
• Form: written;
• Parties: tripartite;
• Incentives: other;
• Co-interventions: yes.
Group 1: Contracting and recording - patients took their daily medication in front of a significant other
and they both recorded, signed and dated it on a standard form.
Group 2: Contracting and recording plus significant other given instructions for reinforcement.
Group 3: Explanations in relation to disulfiram (Antabuse); phone calls to check on use and aid in resolving
difficulties
Outcomes Participants who collected monthly prescriptions for disulfiram (Antabuse) for 3 months. Participants
whose significant other reported disulfiram being taken daily at 3 months, percentage of aftercare sessions
attended
Notes
Risk of bias
Item Authors’ judgement Description
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Keane 1984 (Continued)
Allocation concealment? Unclear B - Unclear
Lash 1998
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: speciality (Veterans Affairs Medical Center inpatient substance abuse treatment program).
Health problem: addictions (alcohol and drugs).
Recruitment: health system.
Participants: adults (n=40).
Interventions Contract features:
• Form: written;
• Parties: patients-practitioners;
• Incentives: none;
• Co-interventions: yes.
Experimental group: aftercare orientation session plus aftercare participation contract.
Control group: videotape of motivational speaker on aftercare
Outcomes Number of aftercare sessions attended.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Litzelman 1993
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: PHC.
Health problem: diabetes.
Recruitment: health system.
Participants: adults (n=395).
Interventions Contract features:
• Form: written;
• Parties: patients-practitioners;
• Incentives: none;
• Co-interventions: yes.
Experimental group: education sessions, individually-negotiates foot care contracts and postal reminders
about foot care.
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Litzelman 1993 (Continued)
Control group: routine care.
Outcomes Foot lesions at 1 year, and various foot care behaviours.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Mayer 1991
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: other.
Health problem: breast self-examination.
Recruitment: adverts.
Participants: female University employees (n=36).
Interventions Contract features:
• Form: written;
• Parties: patients-carers;
• Incentives: deposit;
• Co-interventions: yes.
Experimental group: contract to remind to perform breast self-examination.
Control group: no contracting.
Outcomes Frequency of breast self-examination, and frequency of being prompted
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
McLean 1973
Methods Randomised controlled trial with two groups.
Participants Country: Canada.
Setting: other.
Health problem: depression.
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McLean 1973 (Continued)
Recruitment: health system.
Participants: adults aged 20-55 and their spouses (n=20).
Interventions Contract features:
• Form: NA;
• Parties: patients-carers;
• Incentives: other;
• Co-interventions: yes.
Experimental group: contract between husband and wife relating to the communication between them-
selves, training in social learning principles, and course in immediate feedback.
Control group: usual care and monitoring the course of depression
Outcomes Target communication behaviours and negative reactions.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Morgan 1988
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: speciality.
Health problem: diabetes.
Recruitment: health system and adverts.
Participants: adults (n=60).
Interventions Contract features:
• Form: written;
• Parties: patients-carers;
• Incentives: other;
• Co-interventions: yes.
Experimental group: educational programme on the management of diabetes, with weekly contracts for
behaviour change in exchange for reinforcers such as flowers or lottery tickets.
Control group: similar education programme without contracts
Outcomes Change in weight, fasting blood glucose, glycosylated haemoglobin and knowledge score at week 8
Notes
Risk of bias
Item Authors’ judgement Description
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Morgan 1988 (Continued)
Allocation concealment? Unclear B - Unclear
Morisky 2001
Methods Randomised controlled trial with four groups.
Participants Country: USA.
Setting: PHC.
Health problem: tuberculosis.
Recruitment: health system.
Participants: adolescents (n=794) and their parents.
Interventions Contract features:
• Form: NA;
• Parties: patients-carers;
• Incentives: other;
• Co-interventions: no.
Group 1: Contingency contracts negotiated between adolescents and their parents where the parent
provide an incentive in return for adolescent adhering to prescribed medication.
Group 2: Contingency contracts plus peer counselling.
Group 3: Peer counselling only.
Group 4: Routine care.
Outcomes Completion of treatment.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Murphy 1982
Methods Randomised controlled trial with a 2 x 2 factorial design plus 2 control groups
Participants Country: USA.
Setting: other.
Health problem: overweight.
Recruitment: adverts.
Participants: adults (n=97 couples).
Interventions Contract features:
• Form: written;
• Parties: patients-carers;
• Incentives: tokens;
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Murphy 1982 (Continued)
• Co-interventions: yes.
Group 1: Attended weight loss education sessions alone and made contingency contracts selecting their
own punishments and rewards for specified weight loss behaviours.
Group 2: Attended weight loss education sessions alone and made contingency contracts as for group 1
but agreed and signed by both themselves and their spouse.
Group 3: Attended weight loss education sessions with their spouse and made contingency contracts
selecting their own punishments and rewards for specified weight loss behaviours.
Group 4: Attendedweight loss education sessions alone andmade contingency contracts agreed and signed
by both themselves and their spouse.
Group 5: Attendance at a weight-loss support group.
Group 6: No intervention.
Outcomes Mean weight loss, percentage excess weight loss, and weight reduction index at 10 weeks
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
O’Farrell 1984
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: other.
Health problem: addictions (alcohol).
Recruitment: health system.
Participants: men (n=36) and their wives.
Interventions Contract features:
• Form: written;
• Parties: tripartite;
• Incentives: none;
• Co-interventions: yes.
Group 1: Contract: The husband agrees to take disulfiram (Antabuse) daily and the wife observes and
records it. In return she agrees not to mention any past drinking or any fears about future drinking. Couple
counselling stressing goodwill and caring behaviours.
Group 2: Couple counselling with catharsis, ventilation, sharing of feelings.
Group 3: No marital treatment.
Outcomes Satisfaction with the programme, ability to solve problems and adherence to sessions
Notes
Risk of bias
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O’Farrell 1984 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Ossip-Klein 1984
Methods Cluster randomised controlled trial with two groups.
Participants Country: USA.
Setting: other.
Health problem: addictions (alcohol).
Recruitment: health system.
Participants: adult male (n=50).
Interventions Contract features:
• Form: written;
• Parties: patients-carers;
• Incentives: other;
• Co-interventions: no.
Experimental group: contract with a significant other or self, agreeing to post a prompt calendar in a
prominent place, attend aftercare sessions and telephone at least an hour in advance if unable to attend
aftercare.
Control group: no contracts or prompt calendars.
Outcomes Attendance at aftercare sessions.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Piotrowski 1999
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: speciality.
Health problem: addictions (opiate).
Recruitment: other.
Participants: adults (n=102).
Interventions Contract features:
• Form: written;
• Parties: patients-practitioners;
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Piotrowski 1999 (Continued)
• Incentives: tokens;
• Co-interventions: no.
Experimental group: contracts using monetary (in the form of tokens) rewards for abstinence from illicit
drugs and alcohol as assessed in random tests.
Control group: random tests and feedback only.
Outcomes Number of substance free samples and longest period of abstinence at different follow up times. Costs
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Poole 1981
Methods Randomised controlled trial with four groups.
Participants Country: Australia.
Setting: NA.
Health problem: addictions (smoking).
Recruitment: adverts.
Participants: adults under the age of 50 (n=75).
Interventions Contract features.
• Form: written;
• Parties: patients-carers;
• Incentives: deposit;
• Co-interventions: yes.
Group 1: Rapid smoking sessions.
Group 2: Rapid smoking sessions plus relaxation training.
Group 3: Rapid smoking, relaxation and contingency contracting; drawn up between patient and signif-
icant other to reinforce patients’ not smoking.
Group 4: Contingent rapid smoking; patients who smoked were required to attend extra rapid smoking
sessions
Outcomes Abstinence from smoking from 1 week to 12 months after treatment
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Putnam 1994
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: other.
Health problem: acute infections.
Recruitment: health system.
Participants: students aged 18-26 (n=110).
Interventions Contract features:
• Form: written;
• Parties: self-commitment;
• Incentives: none;
• Co-interventions: no.
Experimental group: patients signed commitment to take all their medication.
Control group: usual care.
Outcomes Adherence based on pill counts, self-reported adherence and additional prescriptions received
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Schulman 1980
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: hospital.
Health problem: hypertension.
Recruitment: health system.
Participants: adults (n=105).
Interventions Contract features:
• Form: written;
• Parties: self-commitment;
• Incentives: other;
• Co-interventions: yes.
Group 1: Education booklet plus contingency contracts with behavioural goals; patients received an agreed
reward from a nurse for certain behaviours.
Group 2: Education booklet.
Group 3: Usual care only.
Outcomes Active patient orientation score, indices of resources score and facts index
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Schulman 1980 (Continued)
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Swain 1981
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: PHC.
Health problem: hypertension.
Recruitment: health system.
Participants: adults (n=115).
Interventions Contract features:
• Form: written;
• Parties: patients-carers;
• Incentives: other;
• Co-interventions: yes.
Group 1: Education booklet plus contingency contracts with behavioural goals; patients received an agreed
reward from a nurse for reaching agreed goals.
Group 2: Education booklet.
Group 3: Usual care only.
Outcomes Change in knowledge score, number of participants discontinuing treatment, diastolic blood pressure
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Vinson 2000
Methods Randomised controlled trial.
Participants Country: USA.
Setting: PHC.
Health problem: addictions (alcohol).
Recruitment: health system.
Participants: adult patients (n=80).
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Vinson 2000 (Continued)
Interventions Contract features:
• Form: written;
• Parties: tripartite;
• Incentives: none;
• Co-interventions: no.
Experimental group: contract for changing drinking behaviour produced using options within a computer
programme, reviewed by a physician and signed by both the physician and the patient.
Control group: screening and baseline assessment.
Outcomes Alcohol Use Disorders Identification Test (AUDIT) and Addiction Severity Index (ASI) scores at 12
months
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Wurtele 1980
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: other.
Health problem: tuberculosis.
Recruitment: adverts.
Participants: students (n=1946).
Interventions Contract features:
• Form: written;
• Parties: patients-practitioners;
• Incentives: none;
• Co-interventions: no.
Group 1: participants were asked for both verbal and written commitment to return.
Group 2: participants were asked for their verbal commitment to return for skin-test reading in 48 hours.
Group 3: participants were told to return to have skin test read 48 hours later
Outcomes Number attending for skin test reading.
Notes
Risk of bias
Item Authors’ judgement Description
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Wurtele 1980 (Continued)
Allocation concealment? Unclear B - Unclear
NA: information not available; PHC: Primary Health Care.
The number of participants reflects the number entering the studies, which may differ from the number analysed.
Parties are categorised as healthcare practitioners, participants/patients, and carers (including peers and significant others). Tripartite
contracts involve patients, carers and healthcare practitioners.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Azrin 1994 Not an RCT
Becona 1997 Not an RCT
Bishai 2003 Not an RCT
Black 1983 Compares two types of contracts
Bowers 1987 Compares two types of contracts
Brubaker 2003 Not an RCT
Budney 2001 No comparison group
Bull 2000 Not an RCT
Calsyn 1996 Does not assess the effects of contracts
Capelli 1990 Not an RCT (see notes)
Christensen 1995 Not an RCT
Coelho 1985 No data on outcomes comparing intervention and control
Cottler 1998 Not an RCT. Not a contract intervention
Cummings 1981 Not an RCT
Davis 1995 Compares two types of contracts
Donaldson 1997 Not an RCT
Epstein 2001 Not a contract intervention
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(Continued)
Feeney 2001 Not an RCT
Feeney 2002 Not an RCT
Fleming 1997 Not a contract intervention
Hamilton 1993 Not a contract intervention
Harzer 2000 Not an RCT
Hennig 1998 Not a contract intervention. No appropriate outcomes
Jeffery 1983 Compares two types of contracts; no control group
Jeffery 1984 Not an RCT (same study as Jeffery 1983)
Jeffrey 1975 Not a contract intervention
Johnson 1991 Not an RCT
Jones 1993 Not an RCT
Kim 1991 Not an RCT
Laidlaw 1999 Not an RCT
Leslie 1991 Not an RCT
Lierman 1994 No data on outcomes comparing contracts with control
Lowe 1997 No appropriate outcomes
Messina 2003 Not a contract intervention
Miller 1995 Not an RCT
Napolitan 1999 Not an RCT
Neale 1991 Not an RCT
Neuberger 1993 Not an RCT
Norton 1980 Not a contract intervention, no appropriate outcomes
Ordman 1985 Not a contract intervention
Pantalon 2001 Not an RCT
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(Continued)
Paxton 1980 Not an RCT
Radojevic 1992 Not an RCT
Resnicow 1997 Only data on outcomes for the intervention group
Sagawa 2003 Not an RCT
Sand 1974 No data on outcomes
Saxon 1993 Not an RCT
Schinke 1976 Not a contract intervention
Solanto 1994 Comparing two types of contracts
Stuart 1976 Not a health related topic
Toseland 1983 Not an RCT
Tusel 1994 Not enough data on outcomes, no response to attempted contact with author(s)
Ureda 1980 Two types of contracts
Van Dover 1985 Not enough data on outcomes, no response to attempted contact with author(s)
Villano 2002 Not an RCT
Wysocki 1989 Not an RCT
Zandee 1996 Not an RCT
For additional information about the exclusion of studies other than RCTs, see the ’Notes’ section.
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D A T A A N D A N A L Y S E S
Comparison 1. Contracts versus control in addictions
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Positive Urine Analysis at 18
months post-treatment entry
1 Mean Difference (IV, Random, 95% CI) Totals not selected
1.1 Any substance 1 Mean Difference (IV, Random, 95% CI) Not estimable
1.2 Opiates 1 Mean Difference (IV, Random, 95% CI) Not estimable
1.3 Cocaine 1 Mean Difference (IV, Random, 95% CI) Not estimable
2 Substance free samples 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Substance free samples
after 120 days of treatment
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
3 Healthcare costs (USD x 1,000) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 1 to 4 months
post-treatment
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
3.2 1 month post-treatment 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
3.3 2 months post-treatment 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
3.4 3 months post-treatment 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
3.5 4 month post-treatment 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4 Longest period of abstinence
(days)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 Continuous abstinence at
30 days post treatment
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.2 Continuous abstinence at
60 days post treatment
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.3 Continuous abstinence at
90 days post treatment
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.4 Continuous abstinence at
120 days post treatment
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.5 Continuous abstinence at
150 days post treatment
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.6 Continuous abstinence at
180 days post treatment
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.7 Substance free samples for
alcohol
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.8 Substance free samples for
amphetamines
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.9 Substance free samples for
barbiturates
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.10 Substance free samples
for benzodiazepines
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.11 Substance free samples
for cocaine
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.12 Substance free samples
for marijuana
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
5 Aftercare sessions attended 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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6 Participants who attended
aftercare sessions
2 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 At least one aftercare
session
1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
6.2 Session one 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
6.3 Session two 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
6.4 Session three 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
6.5 Session four 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
6.6 Session five 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
6.7 Session six 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
6.8 Sessions seven 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
6.9 Session eight 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
7 Participants abstinent from
smoking at several times after
treatment
1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
7.1 One week 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
7.2 One month 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
7.3 Two months 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
7.4 Three months 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
7.5 Six months 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
7.6 Twelve months 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 2. Contracts versus control (supervised exercise or minimal care) in weight control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Weight loss in completers of
treatment at 12 weeks
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Weight loss (pounds)
measured at 12 weeks. Control:
minimal care
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.2 Weight loss (pounds)
measured at 12 weeks. Control:
supervised exercise
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2 Weight loss in completers of
treatment and follow-up at 12
months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Weight loss (pounds)
measured at 12 weeks. Control:
minimal care
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2.2 Weight loss (pounds)
measured at 12 weeks. Control:
supervised exercise
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2.3 Weight loss (pounds)
measured at 1 year after the end
of treatment. Control: minimal
care
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
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2.4 Weight loss (pounds)
measured at 1 year after the
end of treatment. Control:
supervised exercise
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
Comparison 3. Contracts versus control in lower limbs care in diabetes patients
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Physician documentation of
findings about diabetes-related
lesions
1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Ulcers 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Pulse examination 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Dry or cracked skin 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.4 Calluses or corns 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.5 Fungal infection 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.6 Ingrown nails 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.7 Improperly trimmed nails 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.8 Foot or leg cellulitis 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.9 Foot deformities 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.10 Sensory examination 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 4. Contracts versus control in tuberculosis care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Subjects completing care 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Control: counseling 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Control: combined
intervention
1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Control: routine care 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 5. Contract versus control in depression
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Changes of target behaviours
at various stages compared to
pre-treatment (score)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 At mid treatment 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.2 At end treatment 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
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1.3 At 3 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
Comparison 6. Contract versus control in adherence to antibiotics for acute infections
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Subjects having received
additional prescriptions
1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
Analysis 1.1. Comparison 1 Contracts versus control in addictions, Outcome 1 Positive Urine Analysis at 18
months post-treatment entry.
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 1 Contracts versus control in addictions
Outcome: 1 Positive Urine Analysis at 18 months post-treatment entry
Study or subgroup Contracts Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Any substance
Calsyn 1994 176 57.8 (25.4) 177 67.2 (26.3) -9.40 [ -14.79, -4.01 ]
2 Opiates
Calsyn 1994 176 37.4 (25.3) 177 43.8 (29.3) -6.40 [ -12.11, -0.69 ]
3 Cocaine
Calsyn 1994 176 37.5 (30.2) 177 44.3 (33.8) -6.80 [ -13.49, -0.11 ]
-100 -50 0 50 100
Favours contracts Favours control
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Analysis 1.2. Comparison 1 Contracts versus control in addictions, Outcome 2 Substance free samples.
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 1 Contracts versus control in addictions
Outcome: 2 Substance free samples
Study or subgroup Contracts Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Substance free samples after 120 days of treatment
Piotrowski 1999 51 28.5 (41.2) 51 16.3 (28.4) 12.20 [ -1.53, 25.93 ]
-100 -50 0 50 100
Favours control Favours contracts
Analysis 1.3. Comparison 1 Contracts versus control in addictions, Outcome 3 Healthcare costs (USD x
1,000).
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 1 Contracts versus control in addictions
Outcome: 3 Healthcare costs (USD x 1,000)
Study or subgroup Contracts Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 1 to 4 months post-treatment
Piotrowski 1999 22 0.4 (0.78) 23 1.33 (2.84) -0.93 [ -2.14, 0.28 ]
2 1 month post-treatment
Piotrowski 1999 22 0.09 (0.3) 23 0.3 (1) -0.21 [ -0.64, 0.22 ]
3 2 months post-treatment
Piotrowski 1999 22 0.09 (0.25) 23 0.32 (1.25) -0.23 [ -0.75, 0.29 ]
4 3 months post-treatment
Piotrowski 1999 22 0.11 (0.3) 23 0.11 (0.09) 0.0 [ -0.13, 0.13 ]
5 4 month post-treatment
Piotrowski 1999 22 0.11 (0.32) 23 0.6 (1.83) -0.49 [ -1.25, 0.27 ]
-10 -5 0 5 10
Favours contracts Favours control
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Analysis 1.4. Comparison 1 Contracts versus control in addictions, Outcome 4 Longest period of
abstinence (days).
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 1 Contracts versus control in addictions
Outcome: 4 Longest period of abstinence (days)
Study or subgroup Contracts Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Continuous abstinence at 30 days post treatment
Piotrowski 1999 51 1.88 (2.8) 51 1.51 (2.1) 0.37 [ -0.59, 1.33 ]
2 Continuous abstinence at 60 days post treatment
Piotrowski 1999 51 4.12 (6.3) 51 2.22 (3.2) 1.90 [ -0.04, 3.84 ]
3 Continuous abstinence at 90 days post treatment
Piotrowski 1999 51 5.8 (9) 51 2.78 (4) 3.02 [ 0.32, 5.72 ]
4 Continuous abstinence at 120 days post treatment
Piotrowski 1999 51 7.59 (11.8) 51 3.29 (5.3) 4.30 [ 0.75, 7.85 ]
5 Continuous abstinence at 150 days post treatment
Piotrowski 1999 51 8.22 (12.9) 51 3.35 (5.4) 4.87 [ 1.03, 8.71 ]
6 Continuous abstinence at 180 days post treatment
Piotrowski 1999 51 8.45 (13.6) 51 3.35 (5.4) 5.10 [ 1.08, 9.12 ]
7 Substance free samples for alcohol
Piotrowski 1999 33 6.6 (12.5) 36 3.4 (5.3) 3.20 [ -1.40, 7.80 ]
8 Substance free samples for amphetamines
Piotrowski 1999 5 10.8 (15.9) 8 1.5 (2) 9.30 [ -4.71, 23.31 ]
9 Substance free samples for barbiturates
Piotrowski 1999 7 12.8 (7.3) 4 6.9 (7.7) 5.90 [ -3.38, 15.18 ]
10 Substance free samples for benzodiazepines
Piotrowski 1999 23 10.4 (13.7) 22 3 (5.2) 7.40 [ 1.39, 13.41 ]
11 Substance free samples for cocaine
Piotrowski 1999 44 6.8 (11.9) 38 3.9 (5.9) 2.90 [ -1.09, 6.89 ]
12 Substance free samples for marijuana
Piotrowski 1999 26 6.9 (10.6) 22 2.1 (2.6) 4.80 [ 0.58, 9.02 ]
-10 -5 0 5 10
Favours control Favours contracts
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Analysis 1.5. Comparison 1 Contracts versus control in addictions, Outcome 5 Aftercare sessions attended.
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 1 Contracts versus control in addictions
Outcome: 5 Aftercare sessions attended
Study or subgroup Contracts Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Lash 1998 20 3 (3.1) 20 1.4 (2.3) 1.60 [ -0.09, 3.29 ]
-10 -5 0 5 10
Favours control Favours contracts
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Analysis 1.6. Comparison 1 Contracts versus control in addictions, Outcome 6 Participants who attended
aftercare sessions.
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 1 Contracts versus control in addictions
Outcome: 6 Participants who attended aftercare sessions
Study or subgroup Contracts Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 At least one aftercare session
Lash 1998 14/20 8/20 3.50 [ 0.94, 12.97 ]
2 Session one
Ossip-Klein 1984 18/25 9/25 4.57 [ 1.38, 15.11 ]
3 Session two
Ossip-Klein 1984 15/25 9/25 2.67 [ 0.85, 8.37 ]
4 Session three
Ossip-Klein 1984 14/25 7/25 3.27 [ 1.01, 10.62 ]
5 Session four
Ossip-Klein 1984 17/25 9/25 3.78 [ 1.17, 12.19 ]
6 Session five
Ossip-Klein 1984 12/25 7/25 2.37 [ 0.73, 7.68 ]
7 Session six
Ossip-Klein 1984 12/25 4/25 4.85 [ 1.29, 18.25 ]
8 Sessions seven
Ossip-Klein 1984 11/25 5/25 3.14 [ 0.89, 11.06 ]
9 Session eight
Ossip-Klein 1984 6/25 6/25 1.00 [ 0.27, 3.66 ]
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Analysis 1.7. Comparison 1 Contracts versus control in addictions, Outcome 7 Participants abstinent from
smoking at several times after treatment.
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 1 Contracts versus control in addictions
Outcome: 7 Participants abstinent from smoking at several times after treatment
Study or subgroup Contracts Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 One week
Poole 1981 12/18 36/57 1.17 [ 0.38, 3.57 ]
2 One month
Poole 1981 9/18 26/57 1.19 [ 0.41, 3.44 ]
3 Two months
Poole 1981 10/18 24/57 1.72 [ 0.59, 5.00 ]
4 Three months
Poole 1981 6/18 21/57 0.86 [ 0.28, 2.62 ]
5 Six months
Poole 1981 6/18 14/57 1.54 [ 0.49, 4.85 ]
6 Twelve months
Poole 1981 4/18 11/50 1.01 [ 0.28, 3.71 ]
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Analysis 2.1. Comparison 2 Contracts versus control (supervised exercise or minimal care) in weight
control, Outcome 1 Weight loss in completers of treatment at 12 weeks.
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 2 Contracts versus control (supervised exercise or minimal care) in weight control
Outcome: 1 Weight loss in completers of treatment at 12 weeks
Study or subgroup Contracts Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Weight loss (pounds) measured at 12 weeks. Control: minimal care
Craighead 1989 14 8.1 (1.4) 11 4.6 (1.5) 3.50 [ 2.35, 4.65 ]
2 Weight loss (pounds) measured at 12 weeks. Control: supervised exercise
Craighead 1989 14 8.1 (1.4) 17 11 (1.2) -2.90 [ -3.83, -1.97 ]
-10 -5 0 5 10
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Analysis 2.2. Comparison 2 Contracts versus control (supervised exercise or minimal care) in weight
control, Outcome 2 Weight loss in completers of treatment and follow-up at 12 months.
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 2 Contracts versus control (supervised exercise or minimal care) in weight control
Outcome: 2 Weight loss in completers of treatment and follow-up at 12 months
Study or subgroup Contracts Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Weight loss (pounds) measured at 12 weeks. Control: minimal care
Craighead 1989 13 8.4 (1.4) 10 3.5 (1.6) 4.90 [ 3.65, 6.15 ]
2 Weight loss (pounds) measured at 12 weeks. Control: supervised exercise
Craighead 1989 13 8.4 (1.4) 15 11.9 (1.3) -3.50 [ -4.51, -2.49 ]
3 Weight loss (pounds) measured at 1 year after the end of treatment. Control: minimal care
Craighead 1989 13 4.3 (1.5) 10 4.2 (1.7) 0.10 [ -1.23, 1.43 ]
4 Weight loss (pounds) measured at 1 year after the end of treatment. Control: supervised exercise
Craighead 1989 13 4.3 (1.5) 15 10.6 (1.3) -6.30 [ -7.35, -5.25 ]
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Analysis 3.1. Comparison 3 Contracts versus control in lower limbs care in diabetes patients, Outcome 1
Physician documentation of findings about diabetes-related lesions.
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 3 Contracts versus control in lower limbs care in diabetes patients
Outcome: 1 Physician documentation of findings about diabetes-related lesions
Study or subgroup Contracts Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Ulcers
Litzelman 1993 44/185 22/198 2.50 [ 1.43, 4.36 ]
2 Pulse examination
Litzelman 1993 17/185 6/198 3.24 [ 1.25, 8.40 ]
3 Dry or cracked skin
Litzelman 1993 16/185 4/198 4.59 [ 1.51, 14.00 ]
4 Calluses or corns
Litzelman 1993 12/185 2/198 6.80 [ 1.50, 30.80 ]
5 Fungal infection
Litzelman 1993 6/185 1/198 6.60 [ 0.79, 55.38 ]
6 Ingrown nails
Litzelman 1993 5/185 1/198 5.47 [ 0.63, 47.29 ]
7 Improperly trimmed nails
Litzelman 1993 4/185 1/198 4.35 [ 0.48, 39.31 ]
8 Foot or leg cellulitis
Litzelman 1993 5/185 3/198 1.81 [ 0.43, 7.66 ]
9 Foot deformities
Litzelman 1993 3/185 2/198 1.62 [ 0.27, 9.78 ]
10 Sensory examination
Litzelman 1993 9/185 5/198 1.97 [ 0.65, 6.00 ]
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Analysis 4.1. Comparison 4 Contracts versus control in tuberculosis care, Outcome 1 Subjects completing
care.
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 4 Contracts versus control in tuberculosis care
Outcome: 1 Subjects completing care
Study or subgroup Contracts Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Control: counseling
Morisky 2001 152/199 151/188 0.79 [ 0.49, 1.29 ]
2 Control: combined intervention
Morisky 2001 152/199 162/191 0.58 [ 0.35, 0.97 ]
3 Control: routine care
Morisky 2001 152/199 147/189 0.92 [ 0.58, 1.48 ]
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Analysis 5.1. Comparison 5 Contract versus control in depression, Outcome 1 Changes of target
behaviours at various stages compared to pre-treatment (score).
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 5 Contract versus control in depression
Outcome: 1 Changes of target behaviours at various stages compared to pre-treatment (score)
Study or subgroup Contracts Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 At mid treatment
McLean 1973 10 0.9 (0.65) 10 0.37 (0.45) 0.53 [ 0.04, 1.02 ]
2 At end treatment
McLean 1973 10 1.12 (0.7) 10 0.17 (0.45) 0.95 [ 0.43, 1.47 ]
3 At 3 months follow-up
McLean 1973 10 1.12 (0.7) 10 0.43 (0.43) 0.69 [ 0.18, 1.20 ]
-4 -2 0 2 4
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Analysis 6.1. Comparison 6 Contract versus control in adherence to antibiotics for acute infections,
Outcome 1 Subjects having received additional prescriptions.
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 6 Contract versus control in adherence to antibiotics for acute infections
Outcome: 1 Subjects having received additional prescriptions
Study or subgroup Contracts Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Putnam 1994 4/30 6/30 0.62 [ 0.15, 2.45 ]
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A D D I T I O N A L T A B L E S
Table 1. Assessment of methodological quality
Study Randomi-
sation
method
Allo-
cation con-
cealment
Baseline
measures
Practition-
ers blind
Partici-
pants blind
Outcomes
blind
Follow up Consumers
involved
Aragona
1975
Unclear Unclear Adequate Unclear Unclear Unclear Adequate Unclear
Barrera
1977
Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear
Binstock
1988
Unclear Unclear Adequate Unclear Unclear Unclear Adequate Unclear
Brockway
1977
Unclear Unclear Inadequate Unclear Unclear Unclear Adequate Unclear
Burkhart
2002
Adequate Unclear Inadequate Unclear Unclear Unclear Adequate Unclear
Calsyn 1994 Unclear Unclear Inadequate Unclear Unclear Unclear Adequate Unclear
Claydon
1997
Unclear Unclear Adequate Inadequate Adequate Adequate Adequate Unclear
Curry 1988 Adequate Unclear Unclear Unclear Unclear Unclear Adequate Unclear
Flanders
1985
Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear
Craighead
1989
Unclear Unclear Adequate Unclear Unclear Unclear Inadequate Unclear
Haber 1993 Unclear Unclear Adequate Inadequate Adequate Inadequate Adequate Unclear
Hammond
1999
Unclear Unclear Inadequate Inadequate Adequate Adequate Inadequate Unclear
Hoelscher
1986
Unclear Unclear Adequate Unclear Unclear Adequate Adequate Unclear
Keane 1984
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Table 2. ADDICTIONS: Outcomes for each individual study and statistical significance
Study Number
analysed
Contract
details
Co-inter-
vention
Control de-
scription
Control de-
tails
Outcomes:
favouring
interven-
tion
Outcomes:
favouring
control
Outcomes:
no
difference
Brockway
1977
27 Elim-
inate smok-
ing in two
sit-
uations per
week. Sub-
jects mon-
itored their
smoking
behaviour in
detail
/ multi-ses-
sion smok-
ing cessation
programme.
Teach-
ing of relax-
ation. Infor-
mation
on the ef-
fects of stop-
ping smok-
ing
Yes Routine No smoking
cessation
programme.
Mean num-
ber
of cigarettes
smoked at
end of treat-
ment, 3 and
6 months
follow up
Mean num-
ber
of cigarettes
smoked at
12 months
follow up.
Calsyn 1994 353 Contracts
written de-
pending on
achievement
of absti-
nence goals.
- Group (1)
Med-
ication only:
saw counsel-
lor to com-
plete
standard
treatment.
- Group (2)
Standard:
counselling
sessions
and optional
Yes Complex Three
groups (4),
(5) and (6)
, replicating
the inter-
vention con-
ditions but
with-
out contin-
gency con-
tracting
- Time with
positive
urine analy-
ses for opi-
ates (groups
1 versus 4).
- Positive
urine analy-
ses after 9
week stabili-
sation pe-
riod for opi-
ates.
- Positive
urine analy-
ses after 18
months, (a)
regardless of
- Lower dis-
charge
rate in con-
trol group.
- Time with
positive
urine analy-
ses for co-
caine.
- Retention
in treatment
(signifi-
cance not re-
ported).
- Positive
urine analy-
ses after 9
weeks stabil-
isation pe-
riod for co-
caine
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Table 2. ADDICTIONS: Outcomes for each individual study and statistical significance (Continued)
drug educa-
tion classes.
- Group (3)
Enhanced:
as per group
(2) plus re-
lapse
prevention
skill training
group
and weekly
group treat-
ment
the
substance,
(b) for opi-
ates and (c)
for cocaine.
- Time out
of treatment
before read-
mission.
Curry 1988 139 Absolute ab-
stinence /
contingency
contracting.
Yes Complex Relapse pre-
vention:
cold turkey
withdrawal,
identifying
high risk sit-
uations, etc
Percent-
age of partic-
ipants absti-
nent (both
for all partic-
ipants ran-
domised,
and for only
those
who began
the treat-
ment) at sev-
eral periods
(post-treat-
ment up to 1
year)
Keane 1984 25 - Group
(1) Contract
/ recording.
- Group
(2) Contract
/ recording +
instructions
for positive
reinforce-
ment
Yes Complex - Group
(3) Explana-
tions in rela-
tion
to disulfiram
(Antabuse)
; phone calls
to
check on use
of disulfiram
(Antabuse)
and
aid in resolv-
ing difficul-
ties
- Three
months
of disulfiram
(Antabuse)
dispensed
by the phar-
macy.
- disulfiram
(Antabuse)
intake
reported by
other
(signifi-
cance not re-
ported).
- Aftercare
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Table 2. ADDICTIONS: Outcomes for each individual study and statistical significance (Continued)
sessions at-
tended (sig-
nifi-
cance not re-
ported).
Lash 1998 40 After-
care orienta-
tion session
plus after-
care partici-
pation con-
tract
Yes Routine Video-
tape ofmoti-
vational
speaker on
aftercare.
-
Mean num-
ber of ses-
sions
attended.
- Number of
sub-
jects attend-
ing at least
one aftercare
group
session
O’Farrell
1984
36 - Group
(1)Husband
takes disulfi-
ram
(Antabuse)
. Wife ob-
serves
and records
it. In return
she will not
mention any
past drink-
ing
or any fears
about future
drinking
Yes Complex - Group (2)
Interac-
tional
group:
cathar-
sis, ventila-
tion, sharing
of feelings.
- Group
(3) no treat-
ment.
Satis-
faction out-
comes, abil-
ity to solve
problems,
adherence to
sessions (sig-
nificance
level not re-
ported)
. (Data re-
ported
for group 1
and group 2
only)
Ossip-Klein
1984
50 Posting the
prompt cal-
endar;
attending af-
tercare; call-
ing the Alco-
hol Program
if unable to
attend
No Routine Only
telephone
prompt.
Percentage
atten-
dance after-
care sessions
1, 3, 4 and 6
(6 months)
Percentage
attendance
aftercare ses-
sion 2, 5, 7
and 8.
Piotrowski
1999
102 Contin-
gency con-
tracting for
No Routine Random
tests and
feedback
- Longest
period
with contin-
- Substance
free samples
(proportion
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Table 2. ADDICTIONS: Outcomes for each individual study and statistical significance (Continued)
absence of il-
licit drugs.
only. uous absti-
nence at 90
to180 days.
-
Longest pe-
riodwith ab-
stinence
for benzodi-
azepines and
marijuana
of subjects).
- Longest
period
with contin-
uous absti-
nence at 30
to 60 days.
-
Longest pe-
riodwith ab-
sti-
nence for all
substances
but benzodi-
azepines and
marijuana.
- Total costs
of treatment
at 1 to 4
months.
Poole 1981 75 Group (1)
Rapid
smoking
/ relaxation /
contracting.
Yes Behavioural - Group (2)
Rapid
smoking ses-
sion.
- Group (3)
Rapid
smoking /
relaxation.
- Group (4)
Contin-
gent Rapid
smoking.
- Time re-
maining ab-
stinent
(measured
by self-re-
ported daily
cigarette
consump-
tion) similar
between
groups
(measured at
any time pe-
riod from 1
week to 12
months).
- Cigarette
consump-
tion com-
pared with
baseline
smok-
ing, from 1
week to 12
months fol-
low up
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Table 2. ADDICTIONS: Outcomes for each individual study and statistical significance (Continued)
Vinson
2000
69 Produced by
the patient
using a list
of options in
a computer
programme
No Routine Screening
and baseline
assessment.
Change in
Alcohol Use
Disor-
ders Identi-
fication Test
(AUDIT)
scores at 12
months.
(Note: Ad-
dic-
tion Severity
Index
(ASI) scores
not reported
for interven-
tion
and control
group sepa-
rately)
Table 3. HYPERTENSION: Outcomes for each individual study and statistical significance
Study Number
analysed
Contracts
details
Co-inter-
ventions
Control de-
scription
Control de-
tails
Outcomes:
favouring
interven-
tion
Outcomes:
favouring
control
Outcomes:
no
difference
Binstock
1988
112 - Group (1)
Con-
tracts + edu-
cational pro-
gram.
- Group (2)
Con-
tracts + edu-
cational pro-
gramme
+ BP mea-
surement at
home + cal-
endar pills
Yes Educational - Group (3)
Bi-monthly
educational
program.
- Group (4)
Educational
+ BP mea-
surement at
home.
- Group
(5) Calendar
pills.
Change of
blood pres-
sure from
baseline to 1
year follow
up (not sig-
nificant dif-
ferences be-
tween
groups 1, 2,
4 and 5)
Hoelscher
1986
50 - Group (1)
Contracts /
group relax-
ation.
Yes Complex - Group (2)
Individual
relaxation.
- Group (3)
Group relax-
Cost-
effectiveness
(1 versus 2).
Com-
pliance with
relaxation
practices (1
versus 3).
Blood pres-
sure reduc-
tion at 6 and
10 weeks
(not
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Table 3. HYPERTENSION: Outcomes for each individual study and statistical significance (Continued)
ation.
- Group (4)
Waiting list.
significant 1
against 3)
Schulman
1980
91 - Group
(1) Contract
with
behavioural
goals.
Yes Educational - Group (2)
Rou-
tine / edu-
cation book-
lets.
- Group (3)
Routine.
Active Pa-
tient Orien-
tation scores
(see text for
further ex-
planations).
Availability
of treatment
resources
score (1 ver-
sus 2 and 3)
.
Facts related
to the man-
agement
of hyperten-
sion (1 ver-
sus
3). (Patients’
perceptions
of the treat-
ment
rationales or
facts the staff
shared with
them, and of
the resources
available, re-
spectively.)
Facts index
(1 versus 2).
Swain 1981 115 As above Yes Educational As above Change in
knowledge
score (1 ver-
sus 2).
Subjects dis-
continuing
treatment.
Di-
astolic blood
pressure
controlled.
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Table 4. OVERWEIGHT: Outcomes for each individual study and statistical significance
Study Number
analysed
Contracts
details
Co-inter-
vention
Control de-
scription
Control de-
tails
Outcomes:
favouring
interven-
tion
Outcomes:
favouring
control
Outcomes:
no
difference
Aragona
1975
12 - Group (1)
Contracts
plus exercise
programme,
nutri-
tional infor-
mation,
food diary.
- Group (2)
like Group
(1) plus rein-
forcement
(deposit).
Yes - Group (3)
Routine
Weight
change from
start
to end treat-
ment and at
8 weeks fol-
low up
Craighead
1989
62 Group (1)
Con-
tracted exer-
cise / written
lessons.
Yes Complex Instructions
plus
- Group (2)
Supervised
exercise.
- Group
(3) Minimal
contact.
- Among
completers
of the 12
week treat-
ment,
weight loss
measured
at 12 weeks
(groups 1
versus 3).
- Among
completers
of follow up
(1 year)
, weight loss
measured at
12 weeks (1
versus 3)
- Among
completers
of the 12
week treat-
ment,
weight loss
measured
at 12 weeks
(groups 1
versus 2).
- Among
completers
of follow up
(1 year)
, weight loss
measured at
12 weeks (1
versus 2)
- Among
completers
of follow up
(1 year)
, weight loss
measured at
12 months
(1 versus 2)
- Among
completers
of follow up
(1 year)
, weight loss
measured at
12 months
(1 versus 3).
- Treatment
self-reported
as help-
ful (group 1
versus 2).
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Table 4. OVERWEIGHT: Outcomes for each individual study and statistical significance (Continued)
Har-
vard step test
fitness score
pre-
post group 2
(not signifi-
cant in the
others)
Murphy
1982
97 - Group (1)
Sessions at-
tended
alone:
1 party con-
tract.
- Group
(2) Alone: 2
Parties.
- Group (3)
Couple: 1
Party.
- Group (4)
Couple: 2
Parties.
Yes Complex - Group (5)
Support
group.
- Group (6)
Waiting list.
Mean
weight loss,
per-
centage ex-
cess weight
loss, weight
re-
duction in-
dex all at 10
weeks com-
paring
groups 1 to
Table 5. MISCELLANEOUS: Outcomes for each individual study and statistical significance
Study Number
analysed
Contracts
details
Co-inter-
vention
Control de-
scription
Control de-
tails
Outcomes:
favouring
interven-
tion
Outcomes:
favouring
control
Outcomes:
no
difference
Barrera
1977
24 Snake pho-
bia.
- Group
(1) Contract
and self-ad-
minis-
tered desen-
sitisation.
Yes Routine - Group (2)
Self-admin-
istered sys-
tematic de-
sensitisation
(SSD).
- Group (3)
Placebo bib-
liographic
programme.
Sessions at-
tended and
time spent
studying the
materi-
als (group 2
versus 1)
Post-test
or follow-up
score of any
outcome.
Burkhart
2002
42 Asthma.
Contract for
Peak Expira-
tory Flow
Rate (PEFR)
Yes Routine Training in
using peak
flow meter.
Adherence
to PEFR
monitor-
ing; asthma
episodes.
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Table 5. MISCELLANEOUS: Outcomes for each individual study and statistical significance (Continued)
mon-
itoring, rein-
forcement,
tailoring, re-
minders
Claydon
1997
75 Contact
lenses.
Teaching
checklist,
complica-
tions poster,
care regimen
video, regi-
men poster,
book-
let, appoint-
ment re-
minder, tele-
phone call.
Contract
Yes Routine Provision of
contact
lenses, solu-
tions, basic
instructions
and aftercare
All
outcomes (e.
g. wash-
ing hands or
rinsing
lenses).
Flanders
1985
42 Acne.
- Group (1)
Non-con-
tingent con-
tract.
- Group (2)
Con-
tingent con-
tract both
with educa-
tion
+ self moni-
toring medi-
cation card
Yes Complex - Group (3)
Ed-
ucation and
self-moni-
toring card.
- Group (4)
Waiting list.
Compli-
ance. Num-
ber of acne
lesions.
Haber 1993 64 Healthy
diet.
Contracts,
peer support
group inter-
vention and
health edu-
cation
classes
Yes Educational Health edu-
cation
classes.
Increase
in fibre, salt
limited.
Limiting
fats,
sweets; prac-
tice of stress
manage-
ment tech-
niques and
exercises
Hammond
1999
35 Arthritis.
Contracts,
Joint Protec-
Yes Routine No
intervention
(later re-
Joint protec-
tion
Joint protec-
tion
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Table 5. MISCELLANEOUS: Outcomes for each individual study and statistical significance (Continued)
tion educa-
tion group.
ceived active
interven-
tion)
behaviour
score (before
cross-over);
self reported
joint protec-
tion practice
behaviour
score (after
cross-over).
Joint protec-
tion knowl-
edge. Health
related out-
comes
Litzelman
1993
395 Di-
abetes. Con-
tracts and
educational
sessions.
Yes Routine Two health
outcomes (e.
g.
ulcers); five
behaviour
outcomes (e.
g. wash feet)
; four items
in physician
documenta-
tion (e.g. ul-
cers
recorded)
Five health
outcomes (e.
g. ingrowing
nails); seven
behaviour
outcomes (e.
g. trimmed
nails)
and six items
in physician
documenta-
tion
(e.g. record
of foot de-
formities)
Mayer 1991 36 Breast self
examination
(BSE). Con-
tracts, work-
shops (train-
ing on BSE),
prompting /
reminder
options
Yes Educational Workshops
and mail
prompts.
Breast self-
examination
frequency;
frequency of
being
prompted
McLean
1973
20 Depression.
Contract re-
lated to hus-
band
and wife be-
haviour and
training in
social learn-
ing princi-
ples, course
in immedi-
ate feedback
Yes Routine Monitoring
of
the course of
their depres-
sion, plus
usual care
Improve-
ment
in target be-
haviours
at mid treat-
ment, end
treat-
ment and 3
months fol-
low up. De-
crease of
negative re-
action at end
treatment
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Table 5. MISCELLANEOUS: Outcomes for each individual study and statistical significance (Continued)
Morgan
1988
60 Diabetes.
Teaching /
contracts.
Yes Educational For-
mal teaching
plan on
diabetes and
diet.
Knowledge
score change
from week 1
to 8.
Weight loss,
fasting
blood glu-
cose and gly-
co-
sylated hae-
moglobin
decrease in
the 8 week
period
Morisky
2001
794 Tuberculo-
sis.
- Group (1)
Only
contracts.
- Group (2)
Counselling
/ contracts.
Yes Complex - Group (3)
Coun-
selling.
- Group (4)
Routine.
Completion
of treatment
compar-
ing (1) and
(2), favour-
ing (2)
Completion
of treatment
comparing
(1) and (3),
and (1) and
(4)
Putnam
1994
60 Acute in-
fection. Self-
commit-
ment.
No Routine Usual care. Adherence
based on pill
count.
Self-
reported ad-
herence; ad-
ditional pre-
scriptions
received.
Wurtele
1980
1946 Tuberculo-
sis.
- Group (1)
Writ-
ten and ver-
bal commit-
ment to re-
turn for the
skin test
No Routine - Group (2)
Verbal com-
mitment.
- Group (3)
No commit-
ment.
Compli-
ance: group
1 better than
2, and 2 bet-
ter than 3.
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A P P E N D I C E S
Appendix 1. MEDLINE (Ovid) search strategy
1 (contract or contracts or contracting).tw.
2 (agreement or agreements).tw.
3 (concord$ or negotiat$).tw.
4 (goal$ adj setting).tw.
5 or/1-4
6 patient compliance/
7 (compliance or comply or complying or complied).tw.
8 (adherence or adher or adhering or adhered).tw.
9 or/6-8
10 5 and 9
11 exp patient care planning/
12 (care plan$ or case plan$).tw.
13 case management.tw.
14 or/11-13
15 5 and 14
16 exp decision making/
17 (information adj3 shar$).tw.
18 exp professional patient relations/
19 exp consumer participation/
20 informed consent/
21 partnership.tw.
22 or/16-21
23 5 and 22
24 (behavioral adj3 contract$3).tw.
25 (behavioural adj3 contract$3).tw.
26 contingency contract$3.tw.
27 (contingent adj3 (contract$3 or intervention$ or reinforcement)).tw.
28 participation deposit$1.tw.
29 ((refund$or reward$ or incentive$ or penalt$ or punish$) adj5 contingent).tw.
30 ((refund$ or reward$ or incentive$ or penalt$ or punish$) adj5 (contract$ or agree$ or
concord$)).tw.
31 monetary deposit.tw.
32 ((monetary or payment$ or voucher$ or token$) adj3 contingent).tw.
33 or/24-32
34 10 or 15 or 23 or 33
35 randomized controlled trial.pt.
36 controlled clinical trial.pt.
37 randomized controlled trials.sh.
38 random allocation.sh.
39 double blind method.sh.
40 single blind method.sh.
41 or/35-40
42 animals/ not (human/ and animal/)
43 41 not 42
44 clinical trial.pt.
45 exp clinical trials/
46 (clin$ adj25 trial$).ti,ab.
47 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.
48 placebos.sh
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49 placebo$.ti,ab
50 random$.ti,ab.
51 research design.sh.
52 or/44-51
53 52 not 42
54 43 or 53
55 34 and 54
56 cohort studies/ or cohort.tw.
57 (time adj series).tw.
58 (pre test or pretest or (post test or posttest)).tw.
59 or/56-58
60 34 and 59
61 55 or 60
WH A T ’ S N E W
Last assessed as up-to-date: 28 May 2004.
Date Event Description
14 March 2009 Amended Correction of text formatting problem.
H I S T O R Y
Protocol first published: Issue 2, 2004
Review first published: Issue 2, 2007
Date Event Description
29 July 2008 Amended We had used the trial authors’ data where there was a discrepancy between that and the RevMan calcu-
lations. We have amended the review to present only the RevMan data, and this has resulted in minor
changes to the results in relation to three included studies (Lash 1998, Morisky 2001 and Piotrowski
1999). After these amendments, overall fifteen (rather than sixteen) trials reported at least one outcome
that showed statistically signficant differences favouring the contracts group, and six (rather than five)
trials reported at least one outcome that showed differences favouring the control group
2 July 2008 Amended Converted to new review format.
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C O N T R I B U T I O N S O F A U T H O R S
PG and XBC conceptualised the review.
XBC wrote the first drafts of the protocol, and both made changes to the protocol in response to editors’ and external peer-reviewers’
comments.
XBC and KA worked through all stages of the review. MP contributed to the later drafts of the review. PG participated in applying the
inclusion criteria to some studies, resolved disagreements and reviewed the process.
D E C L A R A T I O N S O F I N T E R E S T
None known
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• The Department of Health, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
INCLUSION CRITERIA: the published protocol included quasi-randomised trials, controlled before-and-after studies (CBAs) and
interrupted time series (ITS) analyses. As more RCT’s than expected were found on searching, we subsequently decided to include only
RCTs.
OUTCOMES: We added “Utilisation of health services” in the review as this was found in one of the studies and seems relevant.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Patient Compliance; ∗Physician-Patient Relations; Consumer Participation; Contracts [∗standards]; Health Promotion [∗methods];
Randomized Controlled Trials as Topic
MeSH check words
Humans
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